WO2023277084A1 - Composition for oral cavity - Google Patents
Composition for oral cavity Download PDFInfo
- Publication number
- WO2023277084A1 WO2023277084A1 PCT/JP2022/026030 JP2022026030W WO2023277084A1 WO 2023277084 A1 WO2023277084 A1 WO 2023277084A1 JP 2022026030 W JP2022026030 W JP 2022026030W WO 2023277084 A1 WO2023277084 A1 WO 2023277084A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- zinc
- copper
- potassium
- salts
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 210000000214 mouth Anatomy 0.000 title claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 31
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 15
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims abstract description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 12
- ILXQRAXCLBJOAD-UHFFFAOYSA-N N-(2-hydroxy-2-phenylethyl)-5,5-dimethyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)(C)CC1C(=O)NCC(O)c1ccccc1 ILXQRAXCLBJOAD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004323 potassium nitrate Substances 0.000 claims abstract description 11
- 235000010333 potassium nitrate Nutrition 0.000 claims abstract description 11
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims abstract description 9
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 9
- 229940108925 copper gluconate Drugs 0.000 claims abstract description 9
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 claims abstract description 8
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 claims abstract description 8
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 7
- 229910000365 copper sulfate Inorganic materials 0.000 claims abstract description 7
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 7
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 claims abstract description 7
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims abstract description 7
- 239000011592 zinc chloride Substances 0.000 claims abstract description 7
- 235000005074 zinc chloride Nutrition 0.000 claims abstract description 7
- 239000011746 zinc citrate Substances 0.000 claims abstract description 7
- 235000006076 zinc citrate Nutrition 0.000 claims abstract description 7
- 229940068475 zinc citrate Drugs 0.000 claims abstract description 7
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 7
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 7
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 7
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 7
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 7
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000001103 potassium chloride Substances 0.000 claims abstract description 6
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 6
- 229910001414 potassium ion Inorganic materials 0.000 claims abstract description 6
- 239000004246 zinc acetate Substances 0.000 claims abstract description 6
- 235000013904 zinc acetate Nutrition 0.000 claims abstract description 6
- 239000001508 potassium citrate Substances 0.000 claims abstract description 5
- 229960002635 potassium citrate Drugs 0.000 claims abstract description 5
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims abstract description 5
- 235000011082 potassium citrates Nutrition 0.000 claims abstract description 5
- 235000011118 potassium hydroxide Nutrition 0.000 claims abstract description 5
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims abstract description 5
- 229910052939 potassium sulfate Inorganic materials 0.000 claims abstract description 5
- 235000011151 potassium sulphates Nutrition 0.000 claims abstract description 5
- 239000000551 dentifrice Substances 0.000 claims description 13
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052802 copper Inorganic materials 0.000 claims description 9
- 239000010949 copper Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 229910052718 tin Inorganic materials 0.000 claims description 6
- 239000002324 mouth wash Substances 0.000 claims description 5
- 229940051866 mouthwash Drugs 0.000 claims description 5
- 229960000355 copper sulfate Drugs 0.000 claims description 3
- 239000011135 tin Substances 0.000 claims description 3
- 229960000314 zinc acetate Drugs 0.000 claims description 3
- 229960001939 zinc chloride Drugs 0.000 claims description 3
- -1 aluminum ions Chemical class 0.000 abstract description 73
- 208000025371 Taste disease Diseases 0.000 abstract description 24
- 235000019656 metallic taste Nutrition 0.000 abstract description 24
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 abstract description 4
- 229910001431 copper ion Inorganic materials 0.000 abstract description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 abstract description 3
- 229910001432 tin ion Inorganic materials 0.000 abstract description 3
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 abstract description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 33
- 235000014113 dietary fatty acids Nutrition 0.000 description 27
- 239000000194 fatty acid Substances 0.000 description 27
- 229930195729 fatty acid Natural products 0.000 description 27
- 150000003839 salts Chemical class 0.000 description 22
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 20
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 239000000377 silicon dioxide Substances 0.000 description 12
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 12
- 239000000049 pigment Substances 0.000 description 11
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 11
- 229960003237 betaine Drugs 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 239000011230 binding agent Substances 0.000 description 9
- 239000004359 castor oil Substances 0.000 description 9
- 235000019438 castor oil Nutrition 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 9
- 239000002304 perfume Substances 0.000 description 9
- 150000005846 sugar alcohols Polymers 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 239000003082 abrasive agent Substances 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 229940108928 copper Drugs 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229940034610 toothpaste Drugs 0.000 description 8
- 239000000606 toothpaste Substances 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 7
- 235000016804 zinc Nutrition 0.000 description 7
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 6
- 235000013162 Cocos nucifera Nutrition 0.000 description 6
- 244000060011 Cocos nucifera Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 229940011037 anethole Drugs 0.000 description 6
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 6
- 229940085605 saccharin sodium Drugs 0.000 description 6
- 239000011775 sodium fluoride Substances 0.000 description 6
- 235000013024 sodium fluoride Nutrition 0.000 description 6
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 5
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 150000003863 ammonium salts Chemical class 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Natural products CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 5
- 230000009610 hypersensitivity Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 239000004711 α-olefin Substances 0.000 description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010006326 Breath odour Diseases 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- 208000002064 Dental Plaque Diseases 0.000 description 4
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 235000019477 peppermint oil Nutrition 0.000 description 4
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 4
- 235000010413 sodium alginate Nutrition 0.000 description 4
- 239000000661 sodium alginate Substances 0.000 description 4
- 229940005550 sodium alginate Drugs 0.000 description 4
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229940104261 taurate Drugs 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 3
- 239000005973 Carvone Substances 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 108010001682 Dextranase Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- 244000246386 Mentha pulegium Species 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 3
- 235000004357 Mentha x piperita Nutrition 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 3
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 3
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 3
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 229950010030 dl-alanine Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000001050 hortel pimenta Nutrition 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 229960003975 potassium Drugs 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 108700004121 sarkosyl Proteins 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 3
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 3
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 3
- RUTSRVMUIGMTHJ-UHFFFAOYSA-M sodium;tetradec-1-ene-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCC=CS([O-])(=O)=O RUTSRVMUIGMTHJ-UHFFFAOYSA-M 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 150000003871 sulfonates Chemical class 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 2
- LBIZZGIYNNLXQN-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid Chemical compound CCCCCCCCCCCCOC(=O)CS(O)(=O)=O LBIZZGIYNNLXQN-UHFFFAOYSA-N 0.000 description 2
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical class CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 241000972673 Phellodendron amurense Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000002272 anti-calculus Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 150000001483 arginine derivatives Chemical class 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- YEOCHZFPBYUXMC-UHFFFAOYSA-L copper benzoate Chemical compound [Cu+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 YEOCHZFPBYUXMC-UHFFFAOYSA-L 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium phosphate dihydrate Substances O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical class CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001683 mentha spicata herb oil Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229930007503 menthone Natural products 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- CAVXVRQDZKMZDB-UHFFFAOYSA-M sodium;2-[dodecanoyl(methyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O CAVXVRQDZKMZDB-UHFFFAOYSA-M 0.000 description 2
- 235000019721 spearmint oil Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000009637 wintergreen oil Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 150000000083 (-)-menthol derivatives Chemical class 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- FPJRGEOLQICYQZ-FHLIZLRMSA-N (1r,2s,5r)-n-[4-(cyanomethyl)phenyl]-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1C(=O)NC1=CC=C(CC#N)C=C1 FPJRGEOLQICYQZ-FHLIZLRMSA-N 0.000 description 1
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- YXTDAZMTQFUZHK-ZVGUSBNCSA-L (2r,3r)-2,3-dihydroxybutanedioate;tin(2+) Chemical compound [Sn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O YXTDAZMTQFUZHK-ZVGUSBNCSA-L 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NGCDGPPKVSZGRR-UHFFFAOYSA-J 1,4,6,9-tetraoxa-5-stannaspiro[4.4]nonane-2,3,7,8-tetrone Chemical compound [Sn+4].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O NGCDGPPKVSZGRR-UHFFFAOYSA-J 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical class CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- CLWNPUARORRDFD-UHFFFAOYSA-N 2-hydroxybutanedioic acid;zinc Chemical compound [Zn].OC(=O)C(O)CC(O)=O CLWNPUARORRDFD-UHFFFAOYSA-N 0.000 description 1
- CQMNNMLVXSWLCH-UHFFFAOYSA-B 2-hydroxypropane-1,2,3-tricarboxylate;tin(4+) Chemical compound [Sn+4].[Sn+4].[Sn+4].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O CQMNNMLVXSWLCH-UHFFFAOYSA-B 0.000 description 1
- SKEZDZQGPKHHSH-UHFFFAOYSA-J 2-hydroxypropanoate;tin(4+) Chemical compound [Sn+4].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O SKEZDZQGPKHHSH-UHFFFAOYSA-J 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ILKFYYOGOCVZRU-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid Chemical class CCCCCCCCCCCC(=O)NCCC(O)=O ILKFYYOGOCVZRU-UHFFFAOYSA-N 0.000 description 1
- HKJKXDULJBGDED-UHFFFAOYSA-N 3-(tetradecylamino)propanoic acid Chemical class CCCCCCCCCCCCCCNCCC(O)=O HKJKXDULJBGDED-UHFFFAOYSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical class CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- WXABJFUNSDXVNH-UHFFFAOYSA-N 5-methyl-2-propan-2-yl-n-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NCCC1=CC=CC=N1 WXABJFUNSDXVNH-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000013474 Spilanthes acmella Nutrition 0.000 description 1
- 244000148729 Spilanthes acmella Species 0.000 description 1
- 235000007892 Spilanthes oleracea Nutrition 0.000 description 1
- 229930184148 Spiranthol Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000862969 Stella Species 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 229920006311 Urethane elastomer Polymers 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-IIZJTUPISA-N [2-[(2r,3s,4r)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@@H](O)[C@@H]1O HVUMOYIDDBPOLL-IIZJTUPISA-N 0.000 description 1
- HPWPQTDSGXMKPM-UHFFFAOYSA-L [Cu+2].[O-]P([O-])(F)=O Chemical compound [Cu+2].[O-]P([O-])(F)=O HPWPQTDSGXMKPM-UHFFFAOYSA-L 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- UMRSVAKGZBVPKD-UHFFFAOYSA-N acetic acid;copper Chemical compound [Cu].CC(O)=O UMRSVAKGZBVPKD-UHFFFAOYSA-N 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- OJMOMXZKOWKUTA-UHFFFAOYSA-N aluminum;borate Chemical compound [Al+3].[O-]B([O-])[O-] OJMOMXZKOWKUTA-UHFFFAOYSA-N 0.000 description 1
- KMJRBSYFFVNPPK-UHFFFAOYSA-K aluminum;dodecanoate Chemical compound [Al+3].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O KMJRBSYFFVNPPK-UHFFFAOYSA-K 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- ZCLVNIZJEKLGFA-UHFFFAOYSA-H bis(4,5-dioxo-1,3,2-dioxalumolan-2-yl) oxalate Chemical compound [Al+3].[Al+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O ZCLVNIZJEKLGFA-UHFFFAOYSA-H 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- VGWUQCWVUNUPMX-RJNTXXOISA-L copper;(2e,4e)-hexa-2,4-dienoate Chemical compound [Cu+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O VGWUQCWVUNUPMX-RJNTXXOISA-L 0.000 description 1
- LHBCBDOIAVIYJI-DKWTVANSSA-L copper;(2s)-2-aminobutanedioate Chemical compound [Cu+2].[O-]C(=O)[C@@H](N)CC([O-])=O LHBCBDOIAVIYJI-DKWTVANSSA-L 0.000 description 1
- HIAAPJWEVOPQRI-DFWYDOINSA-L copper;(2s)-2-aminopentanedioate Chemical compound [Cu+2].[O-]C(=O)[C@@H](N)CCC([O-])=O HIAAPJWEVOPQRI-DFWYDOINSA-L 0.000 description 1
- RSJOBNMOMQFPKQ-UHFFFAOYSA-L copper;2,3-dihydroxybutanedioate Chemical compound [Cu+2].[O-]C(=O)C(O)C(O)C([O-])=O RSJOBNMOMQFPKQ-UHFFFAOYSA-L 0.000 description 1
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 description 1
- CMRVDFLZXRTMTH-UHFFFAOYSA-L copper;2-carboxyphenolate Chemical compound [Cu+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O CMRVDFLZXRTMTH-UHFFFAOYSA-L 0.000 description 1
- YVNZDAXVCOOLPC-UHFFFAOYSA-L copper;2-hydroxy-2-phenylacetate Chemical compound [Cu+2].[O-]C(=O)C(O)C1=CC=CC=C1.[O-]C(=O)C(O)C1=CC=CC=C1 YVNZDAXVCOOLPC-UHFFFAOYSA-L 0.000 description 1
- WMYBXRITVYIFCO-UHFFFAOYSA-N copper;2-hydroxybutanedioic acid Chemical compound [Cu].OC(=O)C(O)CC(O)=O WMYBXRITVYIFCO-UHFFFAOYSA-N 0.000 description 1
- DYROSKSLMAPFBZ-UHFFFAOYSA-L copper;2-hydroxypropanoate Chemical compound [Cu+2].CC(O)C([O-])=O.CC(O)C([O-])=O DYROSKSLMAPFBZ-UHFFFAOYSA-L 0.000 description 1
- PUHAKHQMSBQAKT-UHFFFAOYSA-L copper;butanoate Chemical compound [Cu+2].CCCC([O-])=O.CCCC([O-])=O PUHAKHQMSBQAKT-UHFFFAOYSA-L 0.000 description 1
- NSGLMHRMZITSKO-UHFFFAOYSA-L copper;dibromate Chemical compound [Cu+2].[O-]Br(=O)=O.[O-]Br(=O)=O NSGLMHRMZITSKO-UHFFFAOYSA-L 0.000 description 1
- HFDWIMBEIXDNQS-UHFFFAOYSA-L copper;diformate Chemical compound [Cu+2].[O-]C=O.[O-]C=O HFDWIMBEIXDNQS-UHFFFAOYSA-L 0.000 description 1
- LLVVIWYEOKVOFV-UHFFFAOYSA-L copper;diiodate Chemical compound [Cu+2].[O-]I(=O)=O.[O-]I(=O)=O LLVVIWYEOKVOFV-UHFFFAOYSA-L 0.000 description 1
- JDPSPYBMORZJOD-UHFFFAOYSA-L copper;dodecanoate Chemical compound [Cu+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O JDPSPYBMORZJOD-UHFFFAOYSA-L 0.000 description 1
- QYCVHILLJSYYBD-UHFFFAOYSA-L copper;oxalate Chemical compound [Cu+2].[O-]C(=O)C([O-])=O QYCVHILLJSYYBD-UHFFFAOYSA-L 0.000 description 1
- LZJJVTQGPPWQFS-UHFFFAOYSA-L copper;propanoate Chemical compound [Cu+2].CCC([O-])=O.CCC([O-])=O LZJJVTQGPPWQFS-UHFFFAOYSA-L 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- PEVJCYPAFCUXEZ-UHFFFAOYSA-J dicopper;phosphonato phosphate Chemical compound [Cu+2].[Cu+2].[O-]P([O-])(=O)OP([O-])([O-])=O PEVJCYPAFCUXEZ-UHFFFAOYSA-J 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000009627 gardenia yellow Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 229940070808 lauroyl aspartate Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- MAQCMFOLVVSLLK-UHFFFAOYSA-N methyl 4-(bromomethyl)pyridine-2-carboxylate Chemical compound COC(=O)C1=CC(CBr)=CC=N1 MAQCMFOLVVSLLK-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 229940070800 myristoyl glutamate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- FPJRGEOLQICYQZ-UHFFFAOYSA-N n-[4-(cyanomethyl)phenyl]-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(CC#N)C=C1 FPJRGEOLQICYQZ-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940095068 tetradecene Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- FAKFSJNVVCGEEI-UHFFFAOYSA-J tin(4+);disulfate Chemical compound [Sn+4].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O FAKFSJNVVCGEEI-UHFFFAOYSA-J 0.000 description 1
- QUBMWJKTLKIJNN-UHFFFAOYSA-B tin(4+);tetraphosphate Chemical compound [Sn+4].[Sn+4].[Sn+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QUBMWJKTLKIJNN-UHFFFAOYSA-B 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- YJGJRYWNNHUESM-UHFFFAOYSA-J triacetyloxystannyl acetate Chemical compound [Sn+4].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O YJGJRYWNNHUESM-UHFFFAOYSA-J 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- PQGFRBOHUKOXQZ-FSCNPAMSSA-J tris[[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoyl]oxy]stannyl (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Sn+4].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O PQGFRBOHUKOXQZ-FSCNPAMSSA-J 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229940062776 zinc aspartate Drugs 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- SRWMQSFFRFWREA-UHFFFAOYSA-M zinc formate Chemical compound [Zn+2].[O-]C=O SRWMQSFFRFWREA-UHFFFAOYSA-M 0.000 description 1
- 229940071566 zinc glycinate Drugs 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- OMSYGYSPFZQFFP-UHFFFAOYSA-J zinc pyrophosphate Chemical compound [Zn+2].[Zn+2].[O-]P([O-])(=O)OP([O-])([O-])=O OMSYGYSPFZQFFP-UHFFFAOYSA-J 0.000 description 1
- YZSUHNYMDVSXAS-RJNTXXOISA-L zinc;(2e,4e)-hexa-2,4-dienoate Chemical compound [Zn+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O YZSUHNYMDVSXAS-RJNTXXOISA-L 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- POEVDIARYKIEGF-CEOVSRFSSA-L zinc;(2s)-2-aminobutanedioate;hydron Chemical compound [Zn+2].[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O POEVDIARYKIEGF-CEOVSRFSSA-L 0.000 description 1
- LZQDMXSNTYKRAW-RWUXNGIBSA-L zinc;(e)-3-phenylprop-2-enoate Chemical compound [Zn+2].[O-]C(=O)\C=C\C1=CC=CC=C1.[O-]C(=O)\C=C\C1=CC=CC=C1 LZQDMXSNTYKRAW-RWUXNGIBSA-L 0.000 description 1
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 1
- GAMIYQSIKAOVTG-UHFFFAOYSA-L zinc;2-aminopentanedioate Chemical compound [Zn+2].[O-]C(=O)C(N)CCC([O-])=O GAMIYQSIKAOVTG-UHFFFAOYSA-L 0.000 description 1
- ZAABEEUCMDURSM-UHFFFAOYSA-L zinc;3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoate Chemical compound [Zn+2].OCC(C)(C)C(O)C(=O)NCCC([O-])=O.OCC(C)(C)C(O)C(=O)NCCC([O-])=O ZAABEEUCMDURSM-UHFFFAOYSA-L 0.000 description 1
- XLMCDAMBOROREP-UHFFFAOYSA-N zinc;3-phosphonooxypropane-1,2-diolate Chemical compound [Zn+2].OP(O)(=O)OCC([O-])C[O-] XLMCDAMBOROREP-UHFFFAOYSA-N 0.000 description 1
- WDHVIZKSFZNHJB-UHFFFAOYSA-L zinc;butanoate Chemical compound [Zn+2].CCCC([O-])=O.CCCC([O-])=O WDHVIZKSFZNHJB-UHFFFAOYSA-L 0.000 description 1
- JDLYKQWJXAQNNS-UHFFFAOYSA-L zinc;dibenzoate Chemical compound [Zn+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 JDLYKQWJXAQNNS-UHFFFAOYSA-L 0.000 description 1
- TUDPEWOTGHYZBQ-UHFFFAOYSA-L zinc;dibromate Chemical compound [Zn+2].[O-]Br(=O)=O.[O-]Br(=O)=O TUDPEWOTGHYZBQ-UHFFFAOYSA-L 0.000 description 1
- MFMKGXZULQONRI-UHFFFAOYSA-L zinc;diiodate Chemical compound [Zn+2].[O-]I(=O)=O.[O-]I(=O)=O MFMKGXZULQONRI-UHFFFAOYSA-L 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
- SSFRJJARVXKYME-UHFFFAOYSA-L zinc;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Zn+2].[O-]P([O-])(F)=O SSFRJJARVXKYME-UHFFFAOYSA-L 0.000 description 1
- ZPEJZWGMHAKWNL-UHFFFAOYSA-L zinc;oxalate Chemical compound [Zn+2].[O-]C(=O)C([O-])=O ZPEJZWGMHAKWNL-UHFFFAOYSA-L 0.000 description 1
- XDWXRAYGALQIFG-UHFFFAOYSA-L zinc;propanoate Chemical compound [Zn+2].CCC([O-])=O.CCC([O-])=O XDWXRAYGALQIFG-UHFFFAOYSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to an oral composition.
- a copper salt has an effect of suppressing bad breath (Patent Document 1)
- a zinc salt has an effect of suppressing dental plaque (Patent Document 2)
- a tin salt has an anti-caries effect as tin fluoride (Patent Document 3)
- potassium salts are potassium nitrate and potassium chloride.
- aluminum salt aluminum lactate is known to have an effect of suppressing hypersensitivity (Patent Document 8).
- compounds that release metal ions sometimes exhibit a metallic taste, which has been a factor in reducing the usability of oral compositions.
- L-menthol derivatives and/or N-ethyl-p-menthane-3-carboxamide are added to oral compositions containing compounds that release metal ions (Patent Document 4).
- Pyrrolidone carboxylic acid (Patent Document 6) or blending of anethole and polyhydric alcohol in a predetermined ratio (Patent Document 7) has been proposed as means for masking the metallic taste of zinc compounds.
- Patent Documents 1 to 8 can improve the metallic taste during use of oral compositions, they are insufficient to mask the metallic taste after use.
- a beverage is consumed after use of the oral composition (eg, within about 30 minutes after use)
- a strong metallic taste may be perceived, which may detract from the taste of the beverage.
- the intention to use dentifrice during the daytime may decline, and a technique for masking the metallic taste after use is required to improve QOL.
- the present invention has been made in view of the above, and provides an oral composition that contains a compound that releases metal ions and that can suppress not only the metallic taste during use but also the metallic taste after use.
- the present invention provides the following [1] to [8].
- (B)/(A) is 0.00001 or more as a mass ratio.
- amount of component (A-ii) is 10% by mass or less.
- amount of component (B) is 0.000005 to 0.1% by mass.
- component (Ai) from the group consisting of copper gluconate, copper citrate, copper sulfate, zinc chloride, zinc citrate, zinc gluconate, zinc acetate, zinc sulfate, tin fluoride, and aluminum lactate One or two or more selected, The oral composition according to any one of [1] to [5].
- component (A-ii) is one or more selected from potassium nitrate, potassium hydroxide, potassium citrate, potassium chloride, and potassium sulfate; The oral composition according to any one of [1] to [6].
- an oral composition capable of suppressing a metallic taste during and after use despite containing a compound that releases metal ions. Therefore, the oral composition of the present invention can exhibit various effects of the compound that releases metal ions, can achieve a good feeling of use, can be used comfortably throughout the day, and can improve the QOL of the user. is.
- the oral composition contains (A) and (B) components.
- Component (A) is a compound that releases metal ions.
- product performance such as bad breath control effect, dental plaque control effect, caries preventive effect, hypersensitivity control effect and the like.
- a compound that releases metal ions means a compound that can be ionized in an aqueous solution to release (ionize) metal ions (for example, a metal salt).
- Metal ions include, for example, polyvalent metal ions such as copper ions, zinc ions, tin ions, aluminum ions, and potassium ions, and may be one selected from these ions or a combination of two or more thereof.
- Component (A) is one or more selected from (Ai) a compound that releases polyvalent metal ions and (A-ii) a compound that releases potassium ions, and (Ai), (A-ii) or a combination thereof.
- Polyvalent metal ions include, for example, copper ions, zinc, tin, and aluminum.
- Compounds that release copper ions include, for example, copper chloride, copper fluoride, copper fluorosilicate, copper sulfate, copper nitrate, copper hydroxide, copper oxide, copper bromate, copper iodate, copper fluorophosphate, acetic acid Copper, copper formate, copper benzoate, copper citrate, copper tartrate, copper lactate, copper malate, copper mandelate, copper sorbate, copper pyrophosphate, copper pantothenate, copper gluconate, copper phytate, copper glycerophosphate , copper cinnamate, copper butyrate, copper propionate, copper laurate, copper oxalate, copper salicylate, copper glycinate, copper aspartate, copper glutamate, copper chlorophyll.
- Examples of compounds that release zinc ions include zinc chloride, zinc fluoride, zinc fluorosilicate, zinc sulfate, zinc nitrate, zinc hydroxide, zinc oxide, zinc bromate, zinc iodate, zinc fluorophosphate, and acetic acid.
- the (A) component may be a compound that releases metal ions alone, or may be a combination of two or more.
- iris oil clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, laurel oil, chamomile oil, caraway oil, basil oil, marjoram oil, lemon oil, orange oil, lime oil, yuzu oil, nutmeg oil , lavender oil, paracress oil, vanilla oil, cinnamon oil, pimento oil, cinnamon leaf oil, perilla oil, wintergreen oil; menthol, carvone, cinnamic aldehyde, anethole, 1,8-cineole, methyl salicylate, eugenol , thymol, linalool, limonene, menthone, menthyl acetate, citral, decanal, camphor, borneol, pinene, spiranthol, n-decyl alcohol, citronellol, ⁇ -terpineol, citronellyl acetate, cineole, ethyl linalool, vanill
- solvent examples include water (purified water), ethanol and the like, with water being preferred.
- a solvent may be used individually by 1 type, or may be used in combination of 2 or more type.
- the dosage form of the oral composition can be appropriately selected according to the form of use, and is not particularly limited.
- the dosage form for example, it can be prepared in the form of a paste, a liquid, or the like, and if it is a dentifrice, it can be prepared as a toothpaste, a liquid dentifrice, a liquid dentifrice, or a wet dentifrice.
- -Component (B) and its alternative component- B N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide (trade name: CA370, manufacturer: Takasago International Corporation) N-ethyl-p-menthane-3-carboxamide (trade name: WS-3, manufacturer: Simrise Japan) 3-L-menthoxypropane-1,2-diol (manufacturer: Takasago International Corporation) (1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthylcarboxamide (trade name: Evercool180, manufacturer: Givaudan)
- ⁇ Evaluation method> It was evaluated by 4 subjects.
- 1 g of the sample dentifrice composition was placed on a toothbrush (clinica advantage toothbrush, 4-row compact normal, manufactured by Lion Co., Ltd.), and after brushing the teeth for 3 minutes, 10 mL of water was once applied to the oral cavity. rinsed out.
- 10 mL of water was once applied to the oral cavity. rinsed out.
- mouth spray an appropriate amount was sprayed into the oral cavity.
- the metallic taste in the oral cavity immediately after use and the metallic taste when drinking water 30 minutes after use were evaluated according to the following scoring criteria.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The purpose of the present invention is to provide a composition for oral cavity, the composition containing a compound that releases metal ions but still capable of suppressing not only metallic taste during use but also metallic taste after use. The present invention provides a composition for oral cavity, the composition containing: (A-i) a compound such as copper gluconate, copper citrate, copper sulfate, zinc chloride, zinc citrate, zinc gluconate, zinc acetate, zinc salicylate, zinc sulfate, tin fluoride and aluminum lactate, the compound releasing one or more kinds of metal ions that are selected from among copper ions, zinc ions, tin ions and aluminum ions, and/or (A-ii) a compound such as potassium nitrate, potassium hydroxide, potassium citrate, potassium chloride and potassium sulfate, the compound releasing potassium ions; and (B) N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.
Description
本発明は、口腔用組成物に関する。
The present invention relates to an oral composition.
従来より、銅、亜鉛、アルミニウム、鉄、スズ、アルミニウム、カリウムなどの金属イオンを放出する化合物は、歯磨剤等の口腔用組成物に配合されてきた。例えば、銅塩は口臭抑制効果(特許文献1)、亜鉛塩は歯垢抑制効果(特許文献2)、スズ塩はフッ化スズとして虫歯予防効果(特許文献3)、カリウム塩は硝酸カリウム、塩化カリウムとして、アルミニウム塩は乳酸アルミニウムとして、知覚過敏抑制効果(特許文献8)を有することが知られている。しかし、金属イオンを放出する化合物は、金属味を呈することがあり、口腔用組成物の使用感を低下させる一因となっていた。
Conventionally, compounds that release metal ions such as copper, zinc, aluminum, iron, tin, aluminum and potassium have been incorporated into oral compositions such as dentifrices. For example, a copper salt has an effect of suppressing bad breath (Patent Document 1), a zinc salt has an effect of suppressing dental plaque (Patent Document 2), a tin salt has an anti-caries effect as tin fluoride (Patent Document 3), and potassium salts are potassium nitrate and potassium chloride. As an aluminum salt, aluminum lactate is known to have an effect of suppressing hypersensitivity (Patent Document 8). However, compounds that release metal ions sometimes exhibit a metallic taste, which has been a factor in reducing the usability of oral compositions.
金属味を改善する手段として、金属イオンを放出する化合物を含有する口腔用組成物へのL-メントール誘導体及び/又はN-エチル-p-メンタン-3-カルボキサミドの配合(特許文献4)、水溶性銅化合物を含有する口腔用組成物への(1R,2S,5R)-N-(4-(シアノメチル)フェニル)メンチルカルボキサミドと炭素数10以下である有機酸、ポリリン酸、α-アミノ酸及びそれらの塩の配合(特許文献5)。亜鉛化合物の金属味のマスキング手段としてのピロリドンカルボン酸(特許文献6)、又は、所定比率のアネトールと多価アルコール(特許文献7)の配合が提案されている。
As a means of improving metallic taste, L-menthol derivatives and/or N-ethyl-p-menthane-3-carboxamide are added to oral compositions containing compounds that release metal ions (Patent Document 4). (1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthyl carboxamide and organic acid having 10 or less carbon atoms, polyphosphoric acid, α-amino acid, and them to oral composition containing ionic copper compound (Patent Document 5). Pyrrolidone carboxylic acid (Patent Document 6) or blending of anethole and polyhydric alcohol in a predetermined ratio (Patent Document 7) has been proposed as means for masking the metallic taste of zinc compounds.
しかしながら、特許文献1~8の技術は、口腔用組成物を使用中の金属味を改善できても、使用後の金属味のマスキングは不充分であった。例えば、日中など、口腔用組成物の使用後(例えば使用後約30分の間)に飲料を飲むと金属味が強く感じられることがあり、飲料の味を損なうことがある。その結果、日中における歯磨剤の使用意向が低下するおそれもあり、QOL向上のために使用後の金属味のマスキング技術が求められている。
However, although the techniques of Patent Documents 1 to 8 can improve the metallic taste during use of oral compositions, they are insufficient to mask the metallic taste after use. For example, during the daytime, when a beverage is consumed after use of the oral composition (eg, within about 30 minutes after use), a strong metallic taste may be perceived, which may detract from the taste of the beverage. As a result, there is a possibility that the intention to use dentifrice during the daytime may decline, and a technique for masking the metallic taste after use is required to improve QOL.
本発明は、上記に鑑みてなされたものであって、金属イオンを放出する化合物を含むが、使用中の金属味だけでなく、使用後の金属味が抑制できる口腔用組成物を提供する。
The present invention has been made in view of the above, and provides an oral composition that contains a compound that releases metal ions and that can suppress not only the metallic taste during use but also the metallic taste after use.
本発明は、以下の〔1〕~〔8〕を提供する。
〔1〕(A)下記(A-i)及び(A-ii)から選ばれる1種又は2種以上:
(A-i)銅、亜鉛、スズ、及びアルミニウムからなる群より選ばれる1種又は2種以上の金属イオンを放出する化合物、
(A-ii)カリウムイオンを放出する化合物
(B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド
を含有する口腔用組成物。
〔2〕(B)/(A)が質量比として0.00001以上である〔1〕に記載の口腔用組成物。
〔3〕(A-i)成分の量が5質量%以下である〔1〕又は〔2〕に記載の口腔用組成物。
〔4〕(A-ii)成分の量が10質量%以下である〔1〕~〔3〕のいずれか1項に記載の口腔用組成物。
〔5〕(B)成分の量が0.000005~0.1質量%である〔1〕~〔4〕のいずれか1項に記載の口腔用組成物。
〔6〕(A-i)成分が、グルコン酸銅、クエン酸銅、硫酸銅、塩化亜鉛、クエン酸亜鉛、グルコン酸亜鉛、酢酸亜鉛、硫酸亜鉛、フッ化スズ、及び乳酸アルミニウムからなる群より選ばれる1種又は2種以上であり、
〔1〕~〔5〕のいずれか1項に記載の口腔用組成物。
〔7〕(A-ii)成分が、硝酸カリウム、水酸化カリウム、クエン酸カリウム、塩化カリウム、及び硫酸カリウムから選ばれる1種又は2種以上である、
〔1〕~〔6〕のいずれか1項に記載の口腔用組成物。
〔8〕歯磨剤、洗口剤、又はスプレー剤である〔1〕~〔7〕のいずれか1項に記載の口腔用組成物。 The present invention provides the following [1] to [8].
[1] (A) one or more selected from the following (Ai) and (A-ii):
(Ai) a compound that releases one or more metal ions selected from the group consisting of copper, zinc, tin, and aluminum;
(A-ii) a compound that releases potassium ions; and (B) N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.
[2] The composition for oral cavity according to [1], wherein (B)/(A) is 0.00001 or more as a mass ratio.
[3] The composition for oral cavity according to [1] or [2], wherein the amount of component (Ai) is 5% by mass or less.
[4] The oral composition according to any one of [1] to [3], wherein the amount of component (A-ii) is 10% by mass or less.
[5] The composition for oral cavity according to any one of [1] to [4], wherein the amount of component (B) is 0.000005 to 0.1% by mass.
[6] component (Ai) from the group consisting of copper gluconate, copper citrate, copper sulfate, zinc chloride, zinc citrate, zinc gluconate, zinc acetate, zinc sulfate, tin fluoride, and aluminum lactate One or two or more selected,
The oral composition according to any one of [1] to [5].
[7] component (A-ii) is one or more selected from potassium nitrate, potassium hydroxide, potassium citrate, potassium chloride, and potassium sulfate;
The oral composition according to any one of [1] to [6].
[8] The oral composition according to any one of [1] to [7], which is a dentifrice, mouthwash or spray.
〔1〕(A)下記(A-i)及び(A-ii)から選ばれる1種又は2種以上:
(A-i)銅、亜鉛、スズ、及びアルミニウムからなる群より選ばれる1種又は2種以上の金属イオンを放出する化合物、
(A-ii)カリウムイオンを放出する化合物
(B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド
を含有する口腔用組成物。
〔2〕(B)/(A)が質量比として0.00001以上である〔1〕に記載の口腔用組成物。
〔3〕(A-i)成分の量が5質量%以下である〔1〕又は〔2〕に記載の口腔用組成物。
〔4〕(A-ii)成分の量が10質量%以下である〔1〕~〔3〕のいずれか1項に記載の口腔用組成物。
〔5〕(B)成分の量が0.000005~0.1質量%である〔1〕~〔4〕のいずれか1項に記載の口腔用組成物。
〔6〕(A-i)成分が、グルコン酸銅、クエン酸銅、硫酸銅、塩化亜鉛、クエン酸亜鉛、グルコン酸亜鉛、酢酸亜鉛、硫酸亜鉛、フッ化スズ、及び乳酸アルミニウムからなる群より選ばれる1種又は2種以上であり、
〔1〕~〔5〕のいずれか1項に記載の口腔用組成物。
〔7〕(A-ii)成分が、硝酸カリウム、水酸化カリウム、クエン酸カリウム、塩化カリウム、及び硫酸カリウムから選ばれる1種又は2種以上である、
〔1〕~〔6〕のいずれか1項に記載の口腔用組成物。
〔8〕歯磨剤、洗口剤、又はスプレー剤である〔1〕~〔7〕のいずれか1項に記載の口腔用組成物。 The present invention provides the following [1] to [8].
[1] (A) one or more selected from the following (Ai) and (A-ii):
(Ai) a compound that releases one or more metal ions selected from the group consisting of copper, zinc, tin, and aluminum;
(A-ii) a compound that releases potassium ions; and (B) N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.
[2] The composition for oral cavity according to [1], wherein (B)/(A) is 0.00001 or more as a mass ratio.
[3] The composition for oral cavity according to [1] or [2], wherein the amount of component (Ai) is 5% by mass or less.
[4] The oral composition according to any one of [1] to [3], wherein the amount of component (A-ii) is 10% by mass or less.
[5] The composition for oral cavity according to any one of [1] to [4], wherein the amount of component (B) is 0.000005 to 0.1% by mass.
[6] component (Ai) from the group consisting of copper gluconate, copper citrate, copper sulfate, zinc chloride, zinc citrate, zinc gluconate, zinc acetate, zinc sulfate, tin fluoride, and aluminum lactate One or two or more selected,
The oral composition according to any one of [1] to [5].
[7] component (A-ii) is one or more selected from potassium nitrate, potassium hydroxide, potassium citrate, potassium chloride, and potassium sulfate;
The oral composition according to any one of [1] to [6].
[8] The oral composition according to any one of [1] to [7], which is a dentifrice, mouthwash or spray.
本発明によれば、金属イオンを放出する化合物を含有するにもかかわらず、使用中及び使用後の金属味が抑制され得る口腔用組成物が提供される。そのため、本発明の口腔用組成物は、金属イオンを放出する化合物の各種効果を発揮できるとともに、良好な使用感を実現でき、1日を通じて快適に使用でき、利用者のQOLを向上させ得るものである。
According to the present invention, there is provided an oral composition capable of suppressing a metallic taste during and after use despite containing a compound that releases metal ions. Therefore, the oral composition of the present invention can exhibit various effects of the compound that releases metal ions, can achieve a good feeling of use, can be used comfortably throughout the day, and can improve the QOL of the user. is.
口腔用組成物は、(A)及び(B)成分を含む。
The oral composition contains (A) and (B) components.
〔(A):金属イオンを放出する化合物〕
(A)成分は、金属イオンを放出する化合物である。(A)成分を含有することにより、口臭抑制効果、歯垢抑制効果、虫歯予防効果、知覚過敏抑制効果などの製品性能を付与できる。 [(A): Compound that releases metal ions]
Component (A) is a compound that releases metal ions. By containing the component (A), it is possible to impart product performance such as bad breath control effect, dental plaque control effect, caries preventive effect, hypersensitivity control effect and the like.
(A)成分は、金属イオンを放出する化合物である。(A)成分を含有することにより、口臭抑制効果、歯垢抑制効果、虫歯予防効果、知覚過敏抑制効果などの製品性能を付与できる。 [(A): Compound that releases metal ions]
Component (A) is a compound that releases metal ions. By containing the component (A), it is possible to impart product performance such as bad breath control effect, dental plaque control effect, caries preventive effect, hypersensitivity control effect and the like.
本明細書において、金属イオンを放出する化合物とは、水溶液中で電離し金属イオンを放出(イオン化)し得る化合物(例えば、金属塩)を意味する。金属イオンとしては、例えば、銅イオン、亜鉛イオン、スズイオン、アルミニウムイオン等の多価の金属イオンやカリウムイオンが挙げられ、これらから選ばれる1種でもよく、2種以上の組み合わせでもよい。(A)成分は、(A-i)多価金属イオンを放出する化合物、及び(A-ii)カリウムイオンを放出する化合物から選ばれる1種又は2種以上であり、(A-i)、(A-ii)のいずれか、又はこれらの組み合わせとすることができる。
As used herein, a compound that releases metal ions means a compound that can be ionized in an aqueous solution to release (ionize) metal ions (for example, a metal salt). Metal ions include, for example, polyvalent metal ions such as copper ions, zinc ions, tin ions, aluminum ions, and potassium ions, and may be one selected from these ions or a combination of two or more thereof. Component (A) is one or more selected from (Ai) a compound that releases polyvalent metal ions and (A-ii) a compound that releases potassium ions, and (Ai), (A-ii) or a combination thereof.
-(A-i)多価金属イオンを放出する化合物-
多価金属イオンとしては、例えば、銅イオン、亜鉛、スズ、及びアルミニウムが挙げられる。 -(Ai) a compound that releases polyvalent metal ions-
Polyvalent metal ions include, for example, copper ions, zinc, tin, and aluminum.
多価金属イオンとしては、例えば、銅イオン、亜鉛、スズ、及びアルミニウムが挙げられる。 -(Ai) a compound that releases polyvalent metal ions-
Polyvalent metal ions include, for example, copper ions, zinc, tin, and aluminum.
銅イオンを放出する化合物としては、例えば、塩化銅、フッ化銅、フルオロケイ酸銅、硫酸銅、硝酸銅、水酸化銅、酸化銅、臭素酸銅、ヨウ素酸銅、フルオロリン酸銅、酢酸銅、ギ酸銅、安息香酸銅、クエン酸銅、酒石酸銅、乳酸銅、リンゴ酸銅、マンデル酸銅、ソルビン酸銅、ピロリン酸銅、パントテン酸銅、グルコン酸銅、フィチン酸銅、グリセロリン酸銅、ケイ皮酸銅、酪酸銅、プロピオン酸銅、ラウリン酸銅、シュウ酸銅、サリチル酸銅、グリシン銅、アスパラギン酸銅、グルタミン酸銅、銅クロロフィルが挙げられる。
Compounds that release copper ions include, for example, copper chloride, copper fluoride, copper fluorosilicate, copper sulfate, copper nitrate, copper hydroxide, copper oxide, copper bromate, copper iodate, copper fluorophosphate, acetic acid Copper, copper formate, copper benzoate, copper citrate, copper tartrate, copper lactate, copper malate, copper mandelate, copper sorbate, copper pyrophosphate, copper pantothenate, copper gluconate, copper phytate, copper glycerophosphate , copper cinnamate, copper butyrate, copper propionate, copper laurate, copper oxalate, copper salicylate, copper glycinate, copper aspartate, copper glutamate, copper chlorophyll.
亜鉛イオンを放出する化合物としては、例えば、塩化亜鉛、フッ化亜鉛、フルオロケイ酸亜鉛、硫酸亜鉛、硝酸亜鉛、水酸化亜鉛、酸化亜鉛、臭素酸亜鉛、ヨウ素酸亜鉛、フルオロリン酸亜鉛、酢酸亜鉛、ギ酸亜鉛、安息香酸亜鉛、クエン酸亜鉛、酒石酸亜鉛、乳酸亜鉛、リンゴ酸亜鉛、マンデル酸亜鉛、ピロリン酸亜鉛、ソルビン酸亜鉛、パントテン酸亜鉛、グルコン酸亜鉛、フィチン酸亜鉛、グリセロリン酸亜鉛、ケイ皮酸亜鉛、酪酸亜鉛、プロピオン酸亜鉛、ラウリン酸亜鉛、シュウ酸亜鉛、サリチル酸亜鉛、グリシン亜鉛、アスパラギン酸亜鉛、グルタミン酸亜鉛が挙げられる。
Examples of compounds that release zinc ions include zinc chloride, zinc fluoride, zinc fluorosilicate, zinc sulfate, zinc nitrate, zinc hydroxide, zinc oxide, zinc bromate, zinc iodate, zinc fluorophosphate, and acetic acid. Zinc, zinc formate, zinc benzoate, zinc citrate, zinc tartrate, zinc lactate, zinc malate, zinc mandelate, zinc pyrophosphate, zinc sorbate, zinc pantothenate, zinc gluconate, zinc phytate, zinc glycerophosphate , zinc cinnamate, zinc butyrate, zinc propionate, zinc laurate, zinc oxalate, zinc salicylate, zinc glycinate, zinc aspartate, zinc glutamate.
スズイオンを放出する化合物としては、例えば、塩化スズ、フッ化スズ、酢酸スズ、酸化スズ、グルコン酸スズ、シュウ酸スズ、硫酸スズ、乳酸スズ、酒石酸スズ、クエン酸スズ、リンゴ酸スズ、スズ酸ナトリウム、リン酸スズが挙げられる。
Examples of compounds that release tin ions include tin chloride, tin fluoride, tin acetate, tin oxide, tin gluconate, tin oxalate, tin sulfate, tin lactate, tin tartrate, tin citrate, tin malate, stannic acid Sodium, tin phosphate.
アルミニウムイオンを放出する化合物としては、例えば、酢酸アルミニウム、ホウ酸アルミニウム、乳酸アルミニウム、塩化アルミニウム、水酸化アルミニウム、ラウリン酸アルミニウム、シュウ酸アルミニウム、酸化アルミニウム、オレイン酸アルミニウム、リン酸アルミニウム、硫酸アルミニウムが挙げられる。
Examples of compounds that release aluminum ions include aluminum acetate, aluminum borate, aluminum lactate, aluminum chloride, aluminum hydroxide, aluminum laurate, aluminum oxalate, aluminum oxide, aluminum oleate, aluminum phosphate and aluminum sulfate. mentioned.
(A-i)成分としては、グルコン酸銅、クエン酸銅、硫酸銅、塩化亜鉛、クエン酸亜鉛、グルコン酸亜鉛、酢酸亜鉛、硫酸亜鉛、フッ化スズ、及び乳酸アルミニウムが好ましく、グルコン酸亜鉛を少なくとも含むことが好ましい。(A-i)成分は1種単独でも、2種以上の組み合わせでもよい。
Component (Ai) is preferably copper gluconate, copper citrate, copper sulfate, zinc chloride, zinc citrate, zinc gluconate, zinc acetate, zinc sulfate, tin fluoride, and aluminum lactate. It is preferable to include at least Component (Ai) may be used alone or in combination of two or more.
-(A-ii)カリウムイオンを放出する化合物-
カリウムイオンを放出する化合物としては、例えば、硝酸カリウム、水酸化カリウム、クエン酸カリウム、塩化カリウム、及び硫酸カリウムが挙げられ、硝酸カリウムが好ましい。(A-ii)成分は1種単独でも、2種以上の組み合わせでもよい。 -(A-ii) a compound that releases potassium ions-
Compounds that release potassium ions include, for example, potassium nitrate, potassium hydroxide, potassium citrate, potassium chloride, and potassium sulfate, with potassium nitrate being preferred. Component (A-ii) may be used alone or in combination of two or more.
カリウムイオンを放出する化合物としては、例えば、硝酸カリウム、水酸化カリウム、クエン酸カリウム、塩化カリウム、及び硫酸カリウムが挙げられ、硝酸カリウムが好ましい。(A-ii)成分は1種単独でも、2種以上の組み合わせでもよい。 -(A-ii) a compound that releases potassium ions-
Compounds that release potassium ions include, for example, potassium nitrate, potassium hydroxide, potassium citrate, potassium chloride, and potassium sulfate, with potassium nitrate being preferred. Component (A-ii) may be used alone or in combination of two or more.
金属イオンを放出する化合物は、化学的に合成した成分でもよいし、天然物でもよい。天然物としては、例えば茶等の植物、酵母等の微生物、動物等、微量金属としての銅、亜鉛、スズ、アルミニウム等の多価金属、カリウムを含む天然物が挙げられる。
The compound that releases metal ions may be a chemically synthesized component or a natural product. Examples of natural products include plants such as tea, microorganisms such as yeast, animals, polyvalent metals such as copper, zinc, tin and aluminum as trace metals, and natural products containing potassium.
(A)成分は、(A-i)及び(A-ii)のいずれか又は両方を含むことが好ましく、いずれかであることがより好ましい。
The component (A) preferably contains either or both of (Ai) and (A-ii), more preferably either one.
(A)成分は、金属イオンを放出する化合物単独でもよいし、2種以上の組み合わせでもよい。
The (A) component may be a compound that releases metal ions alone, or may be a combination of two or more.
(A)成分の含有量は、使用する金属化合物の種類、組成物の目的とする効能効果により適宜調節可能であるが、一例を挙げると以下のとおりである。
The content of component (A) can be adjusted as appropriate depending on the type of metal compound used and the intended effect of the composition, but an example is as follows.
(A-i)成分の含有量は、口腔用組成物全体(100質量%)に対し、5質量%以下が好ましく、2質量%以下がより好ましく、1質量%以下が更により好ましい。これにより、(B)成分により金属味を十分マスキングでき、使用感が良好となり得る。通常、(A-i)成分の含有量の下限は、0.001質量%以上が好ましく、0.01質量%以上がより好ましく、0.1質量%以上が更に好ましい。これにより、口臭抑制効果、歯垢抑制効果、虫歯予防効果等の(A-i)成分に起因する製品性能を良好に発揮できる。従って、(A-i)成分の含有量は、0.001~5質量%が好ましく、0.01~2質量%がより好ましく、0.1~1質量%が更に好ましい。
The content of component (Ai) is preferably 5% by mass or less, more preferably 2% by mass or less, and even more preferably 1% by mass or less, relative to the entire oral composition (100% by mass). Thereby, the metallic taste can be sufficiently masked by the component (B), and the feeling of use can be improved. Generally, the lower limit of the content of component (Ai) is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and even more preferably 0.1% by mass or more. As a result, the product performance attributed to the component (Ai), such as halitosis control effect, dental plaque control effect, caries prevention effect, etc., can be exhibited satisfactorily. Therefore, the content of component (Ai) is preferably 0.001 to 5% by mass, more preferably 0.01 to 2% by mass, even more preferably 0.1 to 1% by mass.
(A-ii)成分の含有量は、口腔用組成物全体(100質量%)に対し、0.5質量%以上が好ましく、1質量%以上がより好ましく、2質量%以上又は3質量%以上が更に好ましい。これにより、知覚過敏抑制効果を良好に発揮できる。上限は、10質量%以下が好ましく、8質量%以下がより好ましく、7質量%以下又は6質量%以下が更に好ましい。したがって、(A-ii)成分の含有量は、0.5~10質量%が好ましく、1~8質量%がより好ましく、2~7質量%又は3~8質量%がより好ましい。
The content of component (A-ii) is preferably 0.5% by mass or more, more preferably 1% by mass or more, 2% by mass or more, or 3% by mass or more, relative to the entire oral composition (100% by mass). is more preferred. As a result, the effect of suppressing hypersensitivity can be satisfactorily exhibited. The upper limit is preferably 10% by mass or less, more preferably 8% by mass or less, and even more preferably 7% by mass or less or 6% by mass or less. Therefore, the content of component (A-ii) is preferably 0.5 to 10% by mass, more preferably 1 to 8% by mass, and more preferably 2 to 7% by mass or 3 to 8% by mass.
(A)成分の含有量は、(A-i)及び(A-ii)成分のいずれか又は両方を含むかにより調整すればよいが、一例を挙げると、0.001~15質量%が好ましく、0.005~13質量%がより好ましく、0.01~10質量%が更に好ましい。
The content of component (A) may be adjusted depending on whether one or both of components (Ai) and (A-ii) are included. , more preferably 0.005 to 13% by mass, and even more preferably 0.01 to 10% by mass.
〔(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド〕
(B)成分は、N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミドである。(B)成分を含有することにより、使用時だけでなく使用後まで金属味を改善できる。 [(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide]
Component (B) is N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide. By containing the component (B), the metallic taste can be improved not only during use but also after use.
(B)成分は、N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミドである。(B)成分を含有することにより、使用時だけでなく使用後まで金属味を改善できる。 [(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide]
Component (B) is N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide. By containing the component (B), the metallic taste can be improved not only during use but also after use.
(B)成分の含有量の下限は、口腔用組成物全体(100質量%)に対し、0.000005質量%以上が好ましく、0.00001質量%以上がより好ましく、0.00005質量%以上が更に好ましい。これにより、金属味の抑制効果を発揮できる。上限は、0.1%以下が好ましく、0.05質量%以下がより好ましく、0.01質量%以下が更により好ましい。これにより、(B)成分による刺激を適度に抑えることができ、後味の低下を抑制できる。従って、(B)成分の含有量は、0.000005~0.1質量%が好ましく、0.00001~0.05質量%がより好ましく、0.00005~0.01質量%が更に好ましい。
The lower limit of the content of component (B) is preferably 0.000005% by mass or more, more preferably 0.00001% by mass or more, and 0.00005% by mass or more, relative to the entire oral composition (100% by mass). More preferred. Thereby, the effect of suppressing the metallic taste can be exhibited. The upper limit is preferably 0.1% or less, more preferably 0.05% by mass or less, and even more preferably 0.01% by mass or less. As a result, the irritation caused by the component (B) can be moderately suppressed, and the deterioration of the aftertaste can be suppressed. Therefore, the content of component (B) is preferably 0.000005 to 0.1% by mass, more preferably 0.00001 to 0.05% by mass, and even more preferably 0.00005 to 0.01% by mass.
〔(B)/(A)の含有比率〕
(B)成分の含有量の、(A)成分の含有量に対する比率((B)/(A))の下限は、0.00001以上又は0.00002以上が好ましく、0.00005以上、0.00007以上、0.0001以上又は0.0002以上がより好ましく、0.0004以上、0.0005以上又は0.001以上が更に好ましい。これにより、口腔用組成物の金属味を十分抑えることができる。上限は特に制限はなく、1000を超えてもよく、例えば100以下、10以下、0.1以下とすることができる。これにより、口臭抑制効果、歯垢抑制効果、虫歯予防効果、知覚過敏抑制効果等の製品性能を発揮することができる。 [Content ratio of (B)/(A)]
The lower limit of the ratio of the content of component (B) to the content of component (A) ((B)/(A)) is preferably 0.00001 or more, or 0.00002 or more, 0.00005 or more, and 0.00005 or more. 00007 or more, 0.0001 or more, or 0.0002 or more is more preferable, and 0.0004 or more, 0.0005 or more, or 0.001 or more is still more preferable. Thereby, the metallic taste of the composition for oral cavity can be suppressed sufficiently. The upper limit is not particularly limited, and may exceed 1000, for example, 100 or less, 10 or less, or 0.1 or less. As a result, product performance such as halitosis control effect, dental plaque control effect, tooth decay prevention effect, hypersensitivity control effect, etc. can be exhibited.
(B)成分の含有量の、(A)成分の含有量に対する比率((B)/(A))の下限は、0.00001以上又は0.00002以上が好ましく、0.00005以上、0.00007以上、0.0001以上又は0.0002以上がより好ましく、0.0004以上、0.0005以上又は0.001以上が更に好ましい。これにより、口腔用組成物の金属味を十分抑えることができる。上限は特に制限はなく、1000を超えてもよく、例えば100以下、10以下、0.1以下とすることができる。これにより、口臭抑制効果、歯垢抑制効果、虫歯予防効果、知覚過敏抑制効果等の製品性能を発揮することができる。 [Content ratio of (B)/(A)]
The lower limit of the ratio of the content of component (B) to the content of component (A) ((B)/(A)) is preferably 0.00001 or more, or 0.00002 or more, 0.00005 or more, and 0.00005 or more. 00007 or more, 0.0001 or more, or 0.0002 or more is more preferable, and 0.0004 or more, 0.0005 or more, or 0.001 or more is still more preferable. Thereby, the metallic taste of the composition for oral cavity can be suppressed sufficiently. The upper limit is not particularly limited, and may exceed 1000, for example, 100 or less, 10 or less, or 0.1 or less. As a result, product performance such as halitosis control effect, dental plaque control effect, tooth decay prevention effect, hypersensitivity control effect, etc. can be exhibited.
〔任意成分〕
本発明の口腔用組成物は、本発明の効果を損なわない範囲で、(A)及び(B)成分以外の任意成分を含有していてもよい。 [Optional component]
The oral composition of the present invention may contain optional components other than the components (A) and (B) within the range that does not impair the effects of the present invention.
本発明の口腔用組成物は、本発明の効果を損なわない範囲で、(A)及び(B)成分以外の任意成分を含有していてもよい。 [Optional component]
The oral composition of the present invention may contain optional components other than the components (A) and (B) within the range that does not impair the effects of the present invention.
任意成分としては、(A)及び(B)成分以外であればよく、例えば、研磨剤、界面活性剤、湿潤剤、薬効成分、香料、甘味剤、油性成分、防腐剤、粘結剤、pH調整剤、着色剤(色素)、溶媒が挙げられる。以下、具体的に説明する。
Optional components other than components (A) and (B) may be used, and examples include abrasives, surfactants, wetting agents, medicinal ingredients, flavors, sweeteners, oily components, preservatives, binders, and pH. Adjustment agents, colorants (pigments), and solvents are included. A specific description will be given below.
-研磨剤-
研磨剤は、無機研磨剤及び有機研磨剤のいずれでもよい。無機研磨剤としては、例えば、無水ケイ酸、ゼオライト、沈降性シリカ、アルミノシリケート、ジルコノシリケート、結晶性ジルコニウムシリケート、チタン結合性シリカ、シリカゲル等の研磨性シリカ;第2リン酸カルシウム・2水和塩又は無水和物、第1リン酸カルシウム、第2リン酸カルシウム・2水和塩又は無水和物、不溶性メタリン酸カルシウム、第3リン酸カルシウム、第4リン酸カルシウム、第8リン酸カルシウム、ピロリン酸カルシウム等のリン酸カルシウム系化合物;炭酸カルシウム(軽質、重質)等の炭酸カルシウム系研磨剤;水酸化カルシウム、硫酸カルシウム、酸化カルシウム等のカルシウム系研磨剤;無水ケイ酸、ゼオライト、ケイ酸ジルコニウム等のケイ酸系研磨剤;炭酸マグネシウム、第3リン酸マグネシウム等のマグネシウム系研磨剤;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト系研磨剤;二酸化チタン、雲母チタン、酸化チタン等のチタン系材料;ベントナイト等の鉱物が挙げられる。有機研磨剤としては、例えば、ポリメチルメタアクリレート、合成樹脂系研磨剤が挙げられる。研磨剤は、無機研磨剤が好ましく、研磨性シリカがより好ましく、研磨性シリカが更に好ましい。 -Abrasive-
The abrasive may be either an inorganic abrasive or an organic abrasive. Examples of inorganic abrasives include abrasive silica such as silicic anhydride, zeolite, precipitated silica, aluminosilicate, zirconosilicate, crystalline zirconium silicate, titanium-bonded silica, silica gel; dicalcium phosphate dihydrate. Or calcium phosphate compounds such as anhydrous, monocalcium phosphate, dicalcium phosphate dihydrate or anhydrate, insoluble calcium metaphosphate, tricalcium phosphate, tetracalcium phosphate, octacalcium phosphate, calcium pyrophosphate; calcium carbonate (light Calcium carbonate-based abrasives such as calcium hydroxide, calcium sulfate, calcium oxide; Silicic acid-based abrasives such as silicic anhydride, zeolite, and zirconium silicate; magnesium-based abrasives such as magnesium phosphate; apatite-based abrasives such as hydroxyapatite, fluoroapatite and calcium-deficient apatite; titanium-based materials such as titanium dioxide, titanium mica and titanium oxide; and minerals such as bentonite. Examples of organic abrasives include polymethyl methacrylate and synthetic resin abrasives. The abrasive is preferably an inorganic abrasive, more preferably abrasive silica, and still more preferably abrasive silica.
研磨剤は、無機研磨剤及び有機研磨剤のいずれでもよい。無機研磨剤としては、例えば、無水ケイ酸、ゼオライト、沈降性シリカ、アルミノシリケート、ジルコノシリケート、結晶性ジルコニウムシリケート、チタン結合性シリカ、シリカゲル等の研磨性シリカ;第2リン酸カルシウム・2水和塩又は無水和物、第1リン酸カルシウム、第2リン酸カルシウム・2水和塩又は無水和物、不溶性メタリン酸カルシウム、第3リン酸カルシウム、第4リン酸カルシウム、第8リン酸カルシウム、ピロリン酸カルシウム等のリン酸カルシウム系化合物;炭酸カルシウム(軽質、重質)等の炭酸カルシウム系研磨剤;水酸化カルシウム、硫酸カルシウム、酸化カルシウム等のカルシウム系研磨剤;無水ケイ酸、ゼオライト、ケイ酸ジルコニウム等のケイ酸系研磨剤;炭酸マグネシウム、第3リン酸マグネシウム等のマグネシウム系研磨剤;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト系研磨剤;二酸化チタン、雲母チタン、酸化チタン等のチタン系材料;ベントナイト等の鉱物が挙げられる。有機研磨剤としては、例えば、ポリメチルメタアクリレート、合成樹脂系研磨剤が挙げられる。研磨剤は、無機研磨剤が好ましく、研磨性シリカがより好ましく、研磨性シリカが更に好ましい。 -Abrasive-
The abrasive may be either an inorganic abrasive or an organic abrasive. Examples of inorganic abrasives include abrasive silica such as silicic anhydride, zeolite, precipitated silica, aluminosilicate, zirconosilicate, crystalline zirconium silicate, titanium-bonded silica, silica gel; dicalcium phosphate dihydrate. Or calcium phosphate compounds such as anhydrous, monocalcium phosphate, dicalcium phosphate dihydrate or anhydrate, insoluble calcium metaphosphate, tricalcium phosphate, tetracalcium phosphate, octacalcium phosphate, calcium pyrophosphate; calcium carbonate (light Calcium carbonate-based abrasives such as calcium hydroxide, calcium sulfate, calcium oxide; Silicic acid-based abrasives such as silicic anhydride, zeolite, and zirconium silicate; magnesium-based abrasives such as magnesium phosphate; apatite-based abrasives such as hydroxyapatite, fluoroapatite and calcium-deficient apatite; titanium-based materials such as titanium dioxide, titanium mica and titanium oxide; and minerals such as bentonite. Examples of organic abrasives include polymethyl methacrylate and synthetic resin abrasives. The abrasive is preferably an inorganic abrasive, more preferably abrasive silica, and still more preferably abrasive silica.
研磨性シリカは、平均粒径が1~40μmである研磨粒子であることが好ましく、また、研磨性シリカのBET比表面積は、1gあたり80~250平方メートルであることが好ましい。ここで、研磨性シリカの平均粒径はレーザー回折・散乱法で測定される、体積基準のメジアン径(D50)である。
The abrasive silica is preferably abrasive particles with an average particle diameter of 1 to 40 μm, and the BET specific surface area of the abrasive silica is preferably 80 to 250 square meters per 1 g. Here, the average particle diameter of abrasive silica is the volume-based median diameter (D50) measured by a laser diffraction/scattering method.
研磨剤の好ましいRDA値(Radioactive Dentine Abrasion Values)は特に制限はないが、通常50以上、特に50~200のものが好ましい。研磨剤は、造粒物でもよい。斯かる造粒物としては、例えば、水不溶性粉体(例えば、シリカゲル)を顆粒状に造粒してなる粒子が挙げられる。顆粒状に造粒する際、従来公知の任意好適な結合剤を用いてもよい。
The preferred RDA value (Radioactive Dentine Abrasion Value) of the abrasive is not particularly limited, but usually 50 or more, especially 50 to 200 is preferred. The abrasive may be granulated. Examples of such granules include particles obtained by granulating a water-insoluble powder (eg, silica gel) into granules. When granulating into granules, any suitable conventionally known binder may be used.
研磨剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
The abrasive may be used singly or in combination of two or more.
研磨剤の含有量は、口腔用組成物全体(100質量%)に対し、通常、70質量%以下、好ましくは50質量%以下、より好ましくは8~50質量%である。
The content of the abrasive is usually 70% by mass or less, preferably 50% by mass or less, more preferably 8 to 50% by mass, relative to the entire oral composition (100% by mass).
-界面活性剤-
界面活性剤としては、例えば、アニオン界面活性剤、ノニオン界面活性剤、両性界面活性剤、カチオン界面活性剤が挙げられる。 -Surfactant-
Examples of surfactants include anionic surfactants, nonionic surfactants, amphoteric surfactants, and cationic surfactants.
界面活性剤としては、例えば、アニオン界面活性剤、ノニオン界面活性剤、両性界面活性剤、カチオン界面活性剤が挙げられる。 -Surfactant-
Examples of surfactants include anionic surfactants, nonionic surfactants, amphoteric surfactants, and cationic surfactants.
アニオン界面活性剤としては、例えば、アルキル硫酸塩、アシルアミノ酸塩、アシルタウリン塩、α-オレフィンスルホン酸塩、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸塩、ラウリルスルホ酢酸塩が挙げられる。アルキル基、アシル基は直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20である。塩は、薬理学的に許容される塩から選択され得る。薬理学的に許容される塩としては、塩基付加塩及びアミノ酸塩が挙げられる。具体的には例えば、ナトリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、無機塩基塩が好ましく、アルカリ金属塩(例えば、ナトリウム塩)又はアンモニウム塩がより好ましく、ナトリウム塩が更に好ましい。
Examples of anionic surfactants include alkyl sulfates, acyl amino acid salts, acyl taurine salts, α-olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfate, and lauryl sulfoacetate. Alkyl groups and acyl groups may be linear or branched, saturated or unsaturated, and usually have 10 to 20 carbon atoms. Salts may be selected from pharmacologically acceptable salts. Pharmaceutically acceptable salts include base addition salts and amino acid salts. Specific examples include inorganic base salts such as sodium salts, calcium salts, magnesium salts and ammonium salts; organic base salts such as triethylammonium salts, triethanolammonium salts, pyridinium salts and diisopropylammonium salts; basic salts such as arginine salts. Amino acid salts are included. Among them, inorganic base salts are preferred, alkali metal salts (for example, sodium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
アニオン界面活性剤としては、例えば、アルキル硫酸塩、アシルアミノ酸塩、アシルタウリン塩、α-オレフィンスルホン酸塩、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸塩、ラウリルスルホ酢酸塩が挙げられる。アルキル基、アシル基は直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20であり、好ましくは12~18であり、より好ましくは12~14である。塩は、薬理学的に許容される塩から選択され得る。薬理学的に許容される塩としては、例えば、塩基付加塩及びアミノ酸塩が挙げられる。その具体例としては、ナトリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、無機塩基塩が好ましく、アルカリ金属塩(例えば、ナトリウム塩)又はアンモニウム塩がより好ましく、ナトリウム塩がさらに好ましい。
Examples of anionic surfactants include alkyl sulfates, acyl amino acid salts, acyl taurine salts, α-olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfate, and lauryl sulfoacetate. Alkyl groups and acyl groups may be linear or branched, saturated or unsaturated, and usually have 10 to 20 carbon atoms, preferably 12 to 18 carbon atoms, more preferably 12 to 14. Salts may be selected from pharmacologically acceptable salts. Pharmaceutically acceptable salts include, for example, base addition salts and amino acid salts. Specific examples thereof include inorganic base salts such as sodium salts, calcium salts, magnesium salts and ammonium salts; organic base salts such as triethylammonium salts, triethanolammonium salts, pyridinium salts and diisopropylammonium salts; basic salts such as arginine salts. Amino acid salts are included. Among them, inorganic base salts are preferred, alkali metal salts (eg, sodium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
アルキル硫酸塩としては、例えば、ラウリル硫酸塩(ラウリル硫酸ナトリウム)、ミリストイル硫酸塩が挙げられる。アシルアミノ酸塩としては、例えば、ラウロイルサルコシン塩、ミリストイルサルコシン塩等のアシルサルコシン塩;ラウロイルグルタミン酸塩、ミリストイルグルタミン酸塩、パルミトイルグルタミン酸塩等のアシルグルタミン酸塩;N-ラウロイル-N-メチルグリシン塩、ココイルグリシン塩等のアシルグリシン塩;N-ラウロイル-β-アラニン塩、N-ミリスチル-β-アラニン塩、N-ココイル-β-アラニン塩、N-ラウロイル-N-メチル-β-アラニン塩、N-ミリストイル-N-メチル-β-アラニン塩、N-メチル-N-アシルアラニン塩等のアシルアラニン塩;ラウロイルアスパラギン酸塩等のアシルアスパラギン酸塩が挙げられる。アシルタウリン塩としては、例えば、ラウロイルメチルタウリン塩、N-メチル-N-アシルタウリン塩、N-ココイルメチルタウリン塩、ラウロイルメチルタウリン塩が挙げられる。α-オレフィンスルホン酸塩としては、テトラデセンスルホン酸塩等の炭素原子数12~18のα-オレフィンスルホン酸塩が挙げられる。アニオン界面活性剤の他の例としては、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウムが挙げられる。
Examples of alkyl sulfates include lauryl sulfate (sodium lauryl sulfate) and myristoyl sulfate. Acyl amino acid salts include, for example, acyl sarcosine salts such as lauroyl sarcosine salt and myristoyl sarcosine salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycinate and cocoylglycine. Acylglycine salts such as salts; N-lauroyl-β-alanine salt, N-myristyl-β-alanine salt, N-cocoyl-β-alanine salt, N-lauroyl-N-methyl-β-alanine salt, N-myristoyl acylalanine salts such as -N-methyl-β-alanine salts and N-methyl-N-acylalanine salts; and acyl aspartates such as lauroyl aspartate. Acyl taurate salts include, for example, lauroyl methyl taurate, N-methyl-N-acyl taurate, N-cocoyl methyl taurate, and lauroyl methyl taurate. The α-olefin sulfonate includes α-olefin sulfonates having 12 to 18 carbon atoms such as tetradecene sulfonate. Other examples of anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
アニオン界面活性剤は、泡立ち、泡質の良さの点で、スルホン酸基を含有することが好ましく、アルキル硫酸塩、α-オレフィンスルホン酸塩がより好ましい。
The anionic surfactant preferably contains a sulfonic acid group, more preferably an alkyl sulfate or an α-olefin sulfonate, in terms of foaming and good foam quality.
ノニオン界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル(例、ポリオキシエチレンステアリルエーテル)、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル(例、ポリオキシエチレンソルビタンモノステアレート)、アルキロールアミド、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンアルケニルエーテル、(ポリ)グリセリン脂肪酸エステル(例、モノラウリン酸ポリグリセリル)、ショ糖脂肪酸エステル(例、マルトース脂肪酸エステル)、糖アルコール脂肪酸エステル(例、マルチトール脂肪酸エステル、ラクチトール脂肪酸エステル)、脂肪酸ジエタノールアミド(例、ラウリル酸モノ又はジエタノールアミド)、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンポリオキシプロピレン脂肪酸エステルが挙げられる。ポリオキシエチレンアルキルエーテルのアルキル鎖の炭素原子数は、通常、14~18であり、エチレンオキサイド平均付加モル数は、通常、5~30モルである。ポリオキシエチレン硬化ヒマシ油のエチレンオキサイド平均付加モル数は、通常20~100モル、好ましくは20~60モルである。ソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常12~18である。ポリオキシエチレンソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常16~18であり、エチレンオキサイド平均付加モル数は、通常10~40モルである。アルキロールアミドのアルキル鎖の炭素原子数は、通常12~14である。ノニオン界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテルが好ましい。
Examples of nonionic surfactants include polyoxyethylene alkyl ethers (e.g., polyoxyethylene stearyl ether), polyoxyethylene hydrogenated castor oil, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters (e.g., polyoxyethylene sorbitan monosterate). rate), alkylolamide, polyoxyethylene fatty acid ester, polyoxyethylene alkenyl ether, (poly)glycerin fatty acid ester (e.g., polyglyceryl monolaurate), sucrose fatty acid ester (e.g., maltose fatty acid ester), sugar alcohol fatty acid ester ( Examples include maltitol fatty acid esters, lactitol fatty acid esters), fatty acid diethanolamides (eg, lauric acid mono- or diethanolamide), polyoxyethylene-polyoxypropylene copolymers, and polyoxyethylene-polyoxypropylene fatty acid esters. The number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is generally 14-18, and the average number of moles of ethylene oxide added is generally 5-30 mol. The average mole number of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is generally 20 to 100 mol, preferably 20 to 60 mol. The number of carbon atoms in the fatty acid of the sorbitan fatty acid ester is usually 12-18. The number of carbon atoms in the fatty acid of the polyoxyethylene sorbitan fatty acid ester is generally 16-18, and the average number of moles of ethylene oxide added is generally 10-40 mol. The alkyl chain of the alkylolamide usually has 12-14 carbon atoms. Preferred nonionic surfactants are polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene alkyl ether.
両性界面活性剤としては、例えば、アルキルジメチルアミノ酢酸ベタイン(例えば、ラウリルジメチルアミノ酢酸ベタイン)、脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(例えば、コカミドプロピルベタイン)等のベタイン型両性界面活性剤;N-脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルエチレンジアミン塩(例えば、N-ヤシ油脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン)、ヤシ油脂肪酸イミダゾリニウムベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン等のイミダゾリン型両性界面活性剤;ラウリルジメチルアミノ酢酸ベタイン等のアルキルベタインが挙げられる。
Examples of amphoteric surfactants include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine), fatty acid amidopropyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salts (e.g., N-cocoate acyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine), cocoate imidazolinium betaine, 2-alkyl imidazoline type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethylimidazolinium betaine; and alkylbetaines such as lauryldimethylaminoacetate betaine.
カチオン界面活性剤としては、例えば、アルキルアンモニウム塩、アルキルベンジルアンモニウム塩が挙げられる。
Examples of cationic surfactants include alkylammonium salts and alkylbenzylammonium salts.
界面活性剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。界面活性剤の含有量は、口腔用組成物全体(100質量%)に対し、好ましくは10質量%以下、より好ましくは0.1~9質量%、更に好ましくは0.5~8質量%、更により好ましくは1~7質量%である。
The surfactants may be used singly or in combination of two or more. The content of the surfactant is preferably 10% by mass or less, more preferably 0.1 to 9% by mass, still more preferably 0.5 to 8% by mass, relative to the entire oral composition (100% by mass), Even more preferably, it is 1 to 7% by mass.
-湿潤剤-
湿潤剤としては、糖アルコール、糖アルコール以外の多価アルコールが好ましい。糖アルコールとしては、例えば、ソルビトール、エリスリトール、マルチトール、ラクチトール、キシリトール、還元澱粉糖化物等の糖アルコール;グリセリン;エチレングリコール、プロピレングリコール、ジプロピレングリコール、ブチレングリコール、ポリエチレングリコール等の多価アルコールが挙げられる。これらのうち、糖アルコールとしては、ソルビトールが好ましく、多価アルコールとしてはプロピレングリコールが好ましい。湿潤剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -wetting agent-
Preferred humectants are sugar alcohols and polyhydric alcohols other than sugar alcohols. Examples of sugar alcohols include sugar alcohols such as sorbitol, erythritol, maltitol, lactitol, xylitol, and reduced starch saccharification products; glycerin; and polyhydric alcohols such as ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, and polyethylene glycol. mentioned. Among these, sorbitol is preferred as the sugar alcohol, and propylene glycol is preferred as the polyhydric alcohol. Wetting agents may be used singly or in combination of two or more.
湿潤剤としては、糖アルコール、糖アルコール以外の多価アルコールが好ましい。糖アルコールとしては、例えば、ソルビトール、エリスリトール、マルチトール、ラクチトール、キシリトール、還元澱粉糖化物等の糖アルコール;グリセリン;エチレングリコール、プロピレングリコール、ジプロピレングリコール、ブチレングリコール、ポリエチレングリコール等の多価アルコールが挙げられる。これらのうち、糖アルコールとしては、ソルビトールが好ましく、多価アルコールとしてはプロピレングリコールが好ましい。湿潤剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -wetting agent-
Preferred humectants are sugar alcohols and polyhydric alcohols other than sugar alcohols. Examples of sugar alcohols include sugar alcohols such as sorbitol, erythritol, maltitol, lactitol, xylitol, and reduced starch saccharification products; glycerin; and polyhydric alcohols such as ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, and polyethylene glycol. mentioned. Among these, sorbitol is preferred as the sugar alcohol, and propylene glycol is preferred as the polyhydric alcohol. Wetting agents may be used singly or in combination of two or more.
湿潤剤の含有量は、口腔用組成物全体(100質量%)に対し、通常、50質量%以下、好ましくは40質量%以下、より好ましくは1~35質量%又は1~30質量%である。
The content of the humectant is usually 50% by mass or less, preferably 40% by mass or less, more preferably 1 to 35% by mass or 1 to 30% by mass, relative to the entire oral composition (100% by mass). .
-薬用成分-
(A)成分、(B)成分以外の薬用成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、グリチルリチン酸塩、グリチルレチン酸、グリチルレチン酸塩(例えば、グリチルレチン酸ステアリル)、アズレン、ジヒドロコレステロール等の抗炎症剤;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸又はその塩)、塩化リゾチーム等の収斂剤;歯石予防剤、アラニン、グリシン、プロリン、ピロリドンカルボン酸(塩)等のアミノ酸類、オウバク、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。これらのうち、フッ化ナトリウムが好ましい。薬用成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬用成分の含有量は、常法に従って有効量を適宜設定できる。 -Medicinal Ingredients-
Medicinal ingredients other than components (A) and (B) include, for example, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, triclosan, thymol, hinokitiol, bactericidal or antibacterial agents such as lysozyme chloride; Enzymes such as stranase, mutanase, amylase, protease, and litek enzyme; fluorides such as sodium fluoride and sodium monofluorophosphate; ε-aminocaproic acid, allantoin, tranexamic acid, glycyrrhizinate, glycyrrhetinic acid, glycyrrhetinate ( anti-inflammatory agents such as stearyl glycyrrhetinate), azulene and dihydrocholesterol; anticalculus agents such as condensed phosphate and ethanehydroxydiphosphonate; blood flow promoters such as vitamin E (e.g. tocopherol acetate); Hypersensitivity inhibitors such as strontium; coating agents such as hydroxyethylcellulose dimethyldiallylammonium chloride; astringents such as vitamin C (e.g., ascorbic acid or its salts) and lysozyme chloride; anticalculus agents, alanine, glycine, proline, pyrrolidone carvone Amino acids such as acids (salts), plant extracts such as Phellodendron bark, thyme, Scutellaria root, clove, and hamamelis; calopeptide, and polyvinylpyrrolidone. Of these, sodium fluoride is preferred. A medicinal ingredient may be used individually by 1 type, and may be used in combination of 2 or more type. The content of the medicinal ingredient can be appropriately set to an effective amount according to a conventional method.
(A)成分、(B)成分以外の薬用成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、グリチルリチン酸塩、グリチルレチン酸、グリチルレチン酸塩(例えば、グリチルレチン酸ステアリル)、アズレン、ジヒドロコレステロール等の抗炎症剤;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸又はその塩)、塩化リゾチーム等の収斂剤;歯石予防剤、アラニン、グリシン、プロリン、ピロリドンカルボン酸(塩)等のアミノ酸類、オウバク、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。これらのうち、フッ化ナトリウムが好ましい。薬用成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬用成分の含有量は、常法に従って有効量を適宜設定できる。 -Medicinal Ingredients-
Medicinal ingredients other than components (A) and (B) include, for example, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, triclosan, thymol, hinokitiol, bactericidal or antibacterial agents such as lysozyme chloride; Enzymes such as stranase, mutanase, amylase, protease, and litek enzyme; fluorides such as sodium fluoride and sodium monofluorophosphate; ε-aminocaproic acid, allantoin, tranexamic acid, glycyrrhizinate, glycyrrhetinic acid, glycyrrhetinate ( anti-inflammatory agents such as stearyl glycyrrhetinate), azulene and dihydrocholesterol; anticalculus agents such as condensed phosphate and ethanehydroxydiphosphonate; blood flow promoters such as vitamin E (e.g. tocopherol acetate); Hypersensitivity inhibitors such as strontium; coating agents such as hydroxyethylcellulose dimethyldiallylammonium chloride; astringents such as vitamin C (e.g., ascorbic acid or its salts) and lysozyme chloride; anticalculus agents, alanine, glycine, proline, pyrrolidone carvone Amino acids such as acids (salts), plant extracts such as Phellodendron bark, thyme, Scutellaria root, clove, and hamamelis; calopeptide, and polyvinylpyrrolidone. Of these, sodium fluoride is preferred. A medicinal ingredient may be used individually by 1 type, and may be used in combination of 2 or more type. The content of the medicinal ingredient can be appropriately set to an effective amount according to a conventional method.
-香料-
組成物が香料を含むことにより、使用感をより向上させることができる。香料としては、例えば、ペパーミント油、スペアミント油、和種ハッカ油、アニス油、カシア油、ユーカリ油、ウィンターグリーン油、マスチック油、ネロリ油(オレンジフラワー油)、レモングラス油、ジャスミン油、ローズ油、イリス油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、バジル油、マジョラム油、レモン油、オレンジ油、ライム油、柚子油、ナツメグ油、ラベンダー油、パラクレス油、バニラ油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油等の天然精油;メントール、カルボン、シンナミックアルデヒド、アネトール、1,8-シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、デカナール、カンファー、ボルネオール、ピネン、スピラントール、n-デシルアルコール、シトロネロール、α-テルピネオール、シトロネリルアセテート、シネオール、エチルリナロール、ワニリン等の上記天然精油中に含まれる香料成分;エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンズアルデヒド、バニリン、エチルバニリン、フラネオール等の香料成分;N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、メントングリセロールケタール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3カルボキサミド)酢酸エチル、2-イソプロピル-N、2,3-トリメチルブチルアミド、(1R,2S,5R)-N-(4-(シアノメチル)フェニル)メンチルカルボキサミド等の冷感剤、及びいくつかの香料成分や天然精油を組み合わせてなるミント系、フルーツ系、ハーブ系等の各種調合フレーバーが挙げられる。香料としては、上記例示の香料を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Perfume-
When the composition contains a fragrance, the feeling of use can be further improved. Examples of fragrances include peppermint oil, spearmint oil, Japanese peppermint oil, anise oil, cassia oil, eucalyptus oil, wintergreen oil, mastic oil, neroli oil (orange flower oil), lemongrass oil, jasmine oil, and rose oil. , iris oil, clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, laurel oil, chamomile oil, caraway oil, basil oil, marjoram oil, lemon oil, orange oil, lime oil, yuzu oil, nutmeg oil , lavender oil, paracress oil, vanilla oil, cinnamon oil, pimento oil, cinnamon leaf oil, perilla oil, wintergreen oil; menthol, carvone, cinnamic aldehyde, anethole, 1,8-cineole, methyl salicylate, eugenol , thymol, linalool, limonene, menthone, menthyl acetate, citral, decanal, camphor, borneol, pinene, spiranthol, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineole, ethyl linalool, vanillin, etc. Fragrant ingredients contained therein: Ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methylphenylglycidate, benzaldehyde, vanillin, ethyl vanillin, furaneol, etc.; N-ethyl-p - menthane-3-carboxamide, menthyl lactate, menthyl monosuccinate, isopulegol, menthone glycerol ketal, N-(4-cyanomethylphenyl)-p-menthane carboxamide, 3-l-menthoxypropane-1,2-diol, 5-methyl-2-propan-2-yl-N-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide, 3-(p-menthane-3carboxamido)ethyl acetate, 2-isopropyl-N, 2, Cooling agents such as 3-trimethylbutyramide, (1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthylcarboxamide, and mint-based and fruit-based combinations of some fragrance ingredients and natural essential oils , herb-based and the like. As the perfume, one of the above-exemplified perfumes may be used alone, or two or more thereof may be used in combination.
組成物が香料を含むことにより、使用感をより向上させることができる。香料としては、例えば、ペパーミント油、スペアミント油、和種ハッカ油、アニス油、カシア油、ユーカリ油、ウィンターグリーン油、マスチック油、ネロリ油(オレンジフラワー油)、レモングラス油、ジャスミン油、ローズ油、イリス油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、バジル油、マジョラム油、レモン油、オレンジ油、ライム油、柚子油、ナツメグ油、ラベンダー油、パラクレス油、バニラ油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油等の天然精油;メントール、カルボン、シンナミックアルデヒド、アネトール、1,8-シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、デカナール、カンファー、ボルネオール、ピネン、スピラントール、n-デシルアルコール、シトロネロール、α-テルピネオール、シトロネリルアセテート、シネオール、エチルリナロール、ワニリン等の上記天然精油中に含まれる香料成分;エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンズアルデヒド、バニリン、エチルバニリン、フラネオール等の香料成分;N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、メントングリセロールケタール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3カルボキサミド)酢酸エチル、2-イソプロピル-N、2,3-トリメチルブチルアミド、(1R,2S,5R)-N-(4-(シアノメチル)フェニル)メンチルカルボキサミド等の冷感剤、及びいくつかの香料成分や天然精油を組み合わせてなるミント系、フルーツ系、ハーブ系等の各種調合フレーバーが挙げられる。香料としては、上記例示の香料を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Perfume-
When the composition contains a fragrance, the feeling of use can be further improved. Examples of fragrances include peppermint oil, spearmint oil, Japanese peppermint oil, anise oil, cassia oil, eucalyptus oil, wintergreen oil, mastic oil, neroli oil (orange flower oil), lemongrass oil, jasmine oil, and rose oil. , iris oil, clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, laurel oil, chamomile oil, caraway oil, basil oil, marjoram oil, lemon oil, orange oil, lime oil, yuzu oil, nutmeg oil , lavender oil, paracress oil, vanilla oil, cinnamon oil, pimento oil, cinnamon leaf oil, perilla oil, wintergreen oil; menthol, carvone, cinnamic aldehyde, anethole, 1,8-cineole, methyl salicylate, eugenol , thymol, linalool, limonene, menthone, menthyl acetate, citral, decanal, camphor, borneol, pinene, spiranthol, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineole, ethyl linalool, vanillin, etc. Fragrant ingredients contained therein: Ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methylphenylglycidate, benzaldehyde, vanillin, ethyl vanillin, furaneol, etc.; N-ethyl-p - menthane-3-carboxamide, menthyl lactate, menthyl monosuccinate, isopulegol, menthone glycerol ketal, N-(4-cyanomethylphenyl)-p-menthane carboxamide, 3-l-menthoxypropane-1,2-diol, 5-methyl-2-propan-2-yl-N-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide, 3-(p-menthane-3carboxamido)ethyl acetate, 2-isopropyl-N, 2, Cooling agents such as 3-trimethylbutyramide, (1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthylcarboxamide, and mint-based and fruit-based combinations of some fragrance ingredients and natural essential oils , herb-based and the like. As the perfume, one of the above-exemplified perfumes may be used alone, or two or more thereof may be used in combination.
-甘味剤-
組成物が甘味剤を含むことにより、使用感をより向上させることができる。甘味剤としては、例えば、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、グリチルリチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル等が挙げられる。これらのうち、サッカリンナトリウムが好ましい。甘味剤としては、上記例示の甘味剤を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -sweetener-
By including a sweetener in the composition, the feeling of use can be further improved. Sweetening agents include, for example, saccharin, saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, asparatylphenylalanine methyl ester and the like. Of these, saccharin sodium is preferred. As the sweetener, the above-exemplified sweeteners may be used singly or in combination of two or more.
組成物が甘味剤を含むことにより、使用感をより向上させることができる。甘味剤としては、例えば、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、グリチルリチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル等が挙げられる。これらのうち、サッカリンナトリウムが好ましい。甘味剤としては、上記例示の甘味剤を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -sweetener-
By including a sweetener in the composition, the feeling of use can be further improved. Sweetening agents include, for example, saccharin, saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, asparatylphenylalanine methyl ester and the like. Of these, saccharin sodium is preferred. As the sweetener, the above-exemplified sweeteners may be used singly or in combination of two or more.
-油性成分-
油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ヒマシ油、ヤシ油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。油性成分は、上記例示の油性成分を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 - Oily component -
Examples of oily components include hydrocarbons such as squalane, liquid paraffin, petrolatum, and microcrystalline wax; higher alcohols (such as lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, -22 alcohols); higher fatty acids (e.g., fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, and isostearic acid); vegetable oils such as olive oil, castor oil, and coconut oil; fatty acid esters. As the oily component, one of the above-exemplified oily components may be used alone, or two or more thereof may be used in combination.
油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ヒマシ油、ヤシ油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。油性成分は、上記例示の油性成分を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 - Oily component -
Examples of oily components include hydrocarbons such as squalane, liquid paraffin, petrolatum, and microcrystalline wax; higher alcohols (such as lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, -22 alcohols); higher fatty acids (e.g., fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, and isostearic acid); vegetable oils such as olive oil, castor oil, and coconut oil; fatty acid esters. As the oily component, one of the above-exemplified oily components may be used alone, or two or more thereof may be used in combination.
-防腐剤-
組成物が防腐剤を含むことにより、製剤の防腐力を確保できる。防腐剤としては、例えば、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Preservative-
By including a preservative in the composition, the antiseptic power of the formulation can be ensured. Examples of antiseptics include paraoxybenzoic acid esters (eg, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, butyl parahydroxybenzoate), sodium benzoate, and the like. The preservatives may be used singly or in combination of two or more.
組成物が防腐剤を含むことにより、製剤の防腐力を確保できる。防腐剤としては、例えば、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Preservative-
By including a preservative in the composition, the antiseptic power of the formulation can be ensured. Examples of antiseptics include paraoxybenzoic acid esters (eg, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, butyl parahydroxybenzoate), sodium benzoate, and the like. The preservatives may be used singly or in combination of two or more.
-粘結剤-
組成物が任意の粘結剤を含むことにより、粘度を最適化でき、保形性、使用感をより向上させることができる。粘結剤としては、従来公知の任意好適な有機粘結剤、例えば、多糖類、セルロース系粘結剤(例えば、カルボキシメチルセルロース(CMC)、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、その他の多糖系増粘剤(例、キサンタンガム、グアガム、ジェランガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、カラギーナン、アルギン酸ナトリウム)、合成水溶性高分子(例、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルピロリドン、ポリビニルアルコール、アルギン酸プロピレングリコール)、これらの塩が挙げられる。さらには増粘性シリカ、ケイ酸塩、無水ケイ酸等の無機粘結剤を配合することもできる。これらのうち、カルボキシメチルセルロース(例えば、カルボキシメチルセルロースナトリウム)、増粘性シリカが好ましい。粘結剤は1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Binder-
By including an optional binder in the composition, the viscosity can be optimized, and the shape retention and feel during use can be further improved. As the binding agent, any suitable conventionally known organic binding agent such as polysaccharides, cellulose-based binding agents (e.g., carboxymethylcellulose (CMC), hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, cationic cellulose, etc.), other polysaccharide thickeners (e.g., xanthan gum, guar gum, gellan gum, tragacanth gum, karaya gum, gum arabic, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (e.g., sodium polyacrylate, carboxyvinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, propylene glycol alginate) and salts thereof. Furthermore, inorganic binders such as thickening silica, silicates, and silicic anhydride can also be blended. Among these, carboxymethylcellulose (eg, sodium carboxymethylcellulose) and thickening silica are preferred. A caking agent may be used individually by 1 type, and may be used in combination of 2 or more type.
組成物が任意の粘結剤を含むことにより、粘度を最適化でき、保形性、使用感をより向上させることができる。粘結剤としては、従来公知の任意好適な有機粘結剤、例えば、多糖類、セルロース系粘結剤(例えば、カルボキシメチルセルロース(CMC)、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、その他の多糖系増粘剤(例、キサンタンガム、グアガム、ジェランガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、カラギーナン、アルギン酸ナトリウム)、合成水溶性高分子(例、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルピロリドン、ポリビニルアルコール、アルギン酸プロピレングリコール)、これらの塩が挙げられる。さらには増粘性シリカ、ケイ酸塩、無水ケイ酸等の無機粘結剤を配合することもできる。これらのうち、カルボキシメチルセルロース(例えば、カルボキシメチルセルロースナトリウム)、増粘性シリカが好ましい。粘結剤は1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -Binder-
By including an optional binder in the composition, the viscosity can be optimized, and the shape retention and feel during use can be further improved. As the binding agent, any suitable conventionally known organic binding agent such as polysaccharides, cellulose-based binding agents (e.g., carboxymethylcellulose (CMC), hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, cationic cellulose, etc.), other polysaccharide thickeners (e.g., xanthan gum, guar gum, gellan gum, tragacanth gum, karaya gum, gum arabic, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (e.g., sodium polyacrylate, carboxyvinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, propylene glycol alginate) and salts thereof. Furthermore, inorganic binders such as thickening silica, silicates, and silicic anhydride can also be blended. Among these, carboxymethylcellulose (eg, sodium carboxymethylcellulose) and thickening silica are preferred. A caking agent may be used individually by 1 type, and may be used in combination of 2 or more type.
任意の有機粘結剤の含有量は、口腔用組成物全体(100質量%)に対し、0~5質量%であることが好ましく、0.1~4質量%であることがより好ましい。無機粘結剤の含有量は、0~10質量%であることが好ましく、1~8質量%であることがより好ましい。
The content of the optional organic binder is preferably 0 to 5% by mass, more preferably 0.1 to 4% by mass, relative to the entire oral composition (100% by mass). The content of the inorganic binder is preferably 0 to 10% by mass, more preferably 1 to 8% by mass.
-pH調整剤-
組成物がpH調整剤を含むことにより、製剤のpH安定性を確保できる。pH調整剤としては、例えば、フタル酸、クエン酸、コハク酸、酢酸、フマル酸、リンゴ酸、及び乳酸等の有機酸又はそれらの塩(クエン酸ナトリウム)、リン酸(オルトリン酸)等の無機酸又はそれらの塩(例えば、ナトリウム塩及びアンモニウム塩)、水酸化ナトリウム等の水酸化物が挙げられる。無機酸塩としては、例えば、リン酸水素二ナトリウム、リン酸二水素ナトリウムが挙げられる。 -pH adjuster-
By including a pH adjuster in the composition, the pH stability of the formulation can be ensured. Examples of pH adjusters include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid, and lactic acid, salts thereof (sodium citrate), and inorganic acids such as phosphoric acid (orthophosphoric acid). Acids or salts thereof (eg, sodium salts and ammonium salts), and hydroxides such as sodium hydroxide. Examples of inorganic acid salts include disodium hydrogen phosphate and sodium dihydrogen phosphate.
組成物がpH調整剤を含むことにより、製剤のpH安定性を確保できる。pH調整剤としては、例えば、フタル酸、クエン酸、コハク酸、酢酸、フマル酸、リンゴ酸、及び乳酸等の有機酸又はそれらの塩(クエン酸ナトリウム)、リン酸(オルトリン酸)等の無機酸又はそれらの塩(例えば、ナトリウム塩及びアンモニウム塩)、水酸化ナトリウム等の水酸化物が挙げられる。無機酸塩としては、例えば、リン酸水素二ナトリウム、リン酸二水素ナトリウムが挙げられる。 -pH adjuster-
By including a pH adjuster in the composition, the pH stability of the formulation can be ensured. Examples of pH adjusters include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid, and lactic acid, salts thereof (sodium citrate), and inorganic acids such as phosphoric acid (orthophosphoric acid). Acids or salts thereof (eg, sodium salts and ammonium salts), and hydroxides such as sodium hydroxide. Examples of inorganic acid salts include disodium hydrogen phosphate and sodium dihydrogen phosphate.
pH調整剤の含有量は、通常、添加後の口腔用組成物のpHが5~9、好ましくは6~8.5となる量とすることができる。
The content of the pH adjuster can usually be such that the pH of the oral composition after addition is 5 to 9, preferably 6 to 8.5.
本明細書において、pH値は、通常、測定開始から25℃、3分後の値をいう。pH値は、例えば、東亜電波工業社製のpHメーター(型番Hm-30S)を用いて測定することができる。
In this specification, the pH value usually refers to the value after 3 minutes at 25°C from the start of measurement. The pH value can be measured, for example, using a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
-着色剤-
着色剤としては例えば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、タマリンド色素等の天然色素、赤色2号、赤色3号、赤色104号、赤色105号、赤色106号、赤色227号、黄色4号、黄色5号、緑色3号、青色1号等の法定色素、リボフラビン、二酸化チタンが挙げられる。着色剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -coloring agent-
Examples of coloring agents include natural pigments such as safflower red pigment, gardenia yellow pigment, gardenia blue pigment, perilla pigment, monascus pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cocoa pigment, spirulina blue pigment, and tamarind pigment, and red. Legal pigments such as No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, and Blue No. 1, riboflavin, and titanium dioxide. . The colorants may be used singly or in combination of two or more.
着色剤としては例えば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、タマリンド色素等の天然色素、赤色2号、赤色3号、赤色104号、赤色105号、赤色106号、赤色227号、黄色4号、黄色5号、緑色3号、青色1号等の法定色素、リボフラビン、二酸化チタンが挙げられる。着色剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。 -coloring agent-
Examples of coloring agents include natural pigments such as safflower red pigment, gardenia yellow pigment, gardenia blue pigment, perilla pigment, monascus pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cocoa pigment, spirulina blue pigment, and tamarind pigment, and red. Legal pigments such as No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, and Blue No. 1, riboflavin, and titanium dioxide. . The colorants may be used singly or in combination of two or more.
口腔用組成物が着色剤を含む場合、その含有量は、口腔用組成物の全体に対し0.00001~3質量%とすることが好ましい。
When the oral composition contains a coloring agent, the content thereof is preferably 0.00001 to 3% by mass based on the total oral composition.
-溶媒-
溶媒としては、例えば、水(精製水)、エタノール等が挙げられ、水が好ましい。溶媒は1種を単独で用いても2種以上を組み合わせて用いてもよい。 -solvent-
Examples of the solvent include water (purified water), ethanol and the like, with water being preferred. A solvent may be used individually by 1 type, or may be used in combination of 2 or more type.
溶媒としては、例えば、水(精製水)、エタノール等が挙げられ、水が好ましい。溶媒は1種を単独で用いても2種以上を組み合わせて用いてもよい。 -solvent-
Examples of the solvent include water (purified water), ethanol and the like, with water being preferred. A solvent may be used individually by 1 type, or may be used in combination of 2 or more type.
-他の任意成分-
上記以外の任意成分の例としては、ポリイソブチレン、ポリブタジエン、ウレタン、シリコン、天然ゴムが挙げられる。これら他の任意成分の含有量は、本発明の効果を妨げない範囲で適宜設定できる。 -Other optional ingredients-
Examples of optional components other than the above include polyisobutylene, polybutadiene, urethane, silicon, and natural rubber. The content of these other optional components can be appropriately set within a range that does not impair the effects of the present invention.
上記以外の任意成分の例としては、ポリイソブチレン、ポリブタジエン、ウレタン、シリコン、天然ゴムが挙げられる。これら他の任意成分の含有量は、本発明の効果を妨げない範囲で適宜設定できる。 -Other optional ingredients-
Examples of optional components other than the above include polyisobutylene, polybutadiene, urethane, silicon, and natural rubber. The content of these other optional components can be appropriately set within a range that does not impair the effects of the present invention.
〔口腔用組成物の剤形及び用途〕
本発明の口腔用組成物は、歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤等の口腔用製剤とすることができる。 [Dosage form and use of oral composition]
The oral composition of the present invention can be an oral preparation such as a dentifrice, a mouthwash, a spray, a coating, a patch, or an oral dissolving agent.
本発明の口腔用組成物は、歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤等の口腔用製剤とすることができる。 [Dosage form and use of oral composition]
The oral composition of the present invention can be an oral preparation such as a dentifrice, a mouthwash, a spray, a coating, a patch, or an oral dissolving agent.
口腔用組成物の剤形は、利用形態に応じて適宜選択することができ、特に限定されない。剤形としては、例えば、ペースト状、液状等の形態で、歯磨剤であれば練歯磨、液体歯磨、液状歯磨、潤製歯磨として調製できる。
The dosage form of the oral composition can be appropriately selected according to the form of use, and is not particularly limited. As for the dosage form, for example, it can be prepared in the form of a paste, a liquid, or the like, and if it is a dentifrice, it can be prepared as a toothpaste, a liquid dentifrice, a liquid dentifrice, or a wet dentifrice.
〔組成物の製造方法〕
口腔用組成物の製造方法は特に限定されず、剤形に応じて、それぞれの通常の方法で調製され得る。例えば練歯磨剤として利用する場合、溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて脱泡(例えば、減圧)を行う方法が挙げられる。得られる練歯磨は、容器に収容して製品とすることができる。容器は、形状、材質は特に制限されず、通常の歯磨剤組成物に使用される容器を使用でき、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック製のラミネートチューブ等の容器等が挙げられる。 [Method for producing composition]
The method for producing the oral composition is not particularly limited, and it can be prepared by each usual method depending on the dosage form. For example, when it is used as a toothpaste, there is a method of preparing components that dissolve in a solvent, mixing other insoluble components, and defoaming (for example, reducing pressure) as necessary. The obtained toothpaste can be stored in a container to be used as a product. The shape and material of the container are not particularly limited, and any container commonly used for dentifrice compositions can be used. Examples include containers such as laminated tubes made of plastic such as polyethylene, polypropylene, polyethylene terephthalate, and nylon. be done.
口腔用組成物の製造方法は特に限定されず、剤形に応じて、それぞれの通常の方法で調製され得る。例えば練歯磨剤として利用する場合、溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて脱泡(例えば、減圧)を行う方法が挙げられる。得られる練歯磨は、容器に収容して製品とすることができる。容器は、形状、材質は特に制限されず、通常の歯磨剤組成物に使用される容器を使用でき、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック製のラミネートチューブ等の容器等が挙げられる。 [Method for producing composition]
The method for producing the oral composition is not particularly limited, and it can be prepared by each usual method depending on the dosage form. For example, when it is used as a toothpaste, there is a method of preparing components that dissolve in a solvent, mixing other insoluble components, and defoaming (for example, reducing pressure) as necessary. The obtained toothpaste can be stored in a container to be used as a product. The shape and material of the container are not particularly limited, and any container commonly used for dentifrice compositions can be used. Examples include containers such as laminated tubes made of plastic such as polyethylene, polypropylene, polyethylene terephthalate, and nylon. be done.
以下、実施例及び比較例を示して本発明を具体的に説明するが、本発明は下記実施例に制限されるものではない。なお、各例中の%はいずれも質量百分率である。
The present invention will be specifically described below with reference to examples and comparative examples, but the present invention is not limited to the following examples. Note that % in each example is mass percentage.
実施例1~22及び比較例1~5
表1~5及び7に示す組成の歯磨剤組成物(練歯磨)をそれぞれ常法によって調製し、通常の口腔用製剤容器(練歯磨:ラミネートチューブ)に収容した。また、表6に示す組成のスプレー組成物を情報によって調整し、通常のマウススプレー容器に収容した。これらをサンプルとして用い、下記に示す方法で評価した。結果を表1~6に併記した。 Examples 1-22 and Comparative Examples 1-5
Dentifrice compositions (toothpaste) having compositions shown in Tables 1 to 5 and 7 were each prepared by a conventional method and housed in a conventional oral formulation container (toothpaste: laminated tube). In addition, a spray composition having the composition shown in Table 6 was prepared according to the information and contained in a conventional mouth spray container. These were used as samples and evaluated by the methods described below. The results are also shown in Tables 1-6.
表1~5及び7に示す組成の歯磨剤組成物(練歯磨)をそれぞれ常法によって調製し、通常の口腔用製剤容器(練歯磨:ラミネートチューブ)に収容した。また、表6に示す組成のスプレー組成物を情報によって調整し、通常のマウススプレー容器に収容した。これらをサンプルとして用い、下記に示す方法で評価した。結果を表1~6に併記した。 Examples 1-22 and Comparative Examples 1-5
Dentifrice compositions (toothpaste) having compositions shown in Tables 1 to 5 and 7 were each prepared by a conventional method and housed in a conventional oral formulation container (toothpaste: laminated tube). In addition, a spray composition having the composition shown in Table 6 was prepared according to the information and contained in a conventional mouth spray container. These were used as samples and evaluated by the methods described below. The results are also shown in Tables 1-6.
<使用した原料>
―(A)成分―
A1:グルコン酸銅(商品名:グルコン酸銅、メーカー:富士フィルム和光純薬株式会社)
A2:クエン酸銅(商品名:クエン酸銅、メーカー:関東化学株式会社)
A3:硫酸銅(商品名:硫酸銅、メーカー:関東化学株式会社)
A4:塩化亜鉛(商品名:塩化亜鉛、メーカー:富士フィルム和光純薬株式会社)
A5:クエン酸亜鉛(商品名:クエン酸亜鉛、メーカー:関東化学株式会社)
A6:グルコン酸亜鉛(商品名:グルコン酸亜鉛、メーカー:富士フィルム和光純薬株式会社)
A7:酢酸亜鉛(商品名:酢酸亜鉛、メーカー:富士フィルム和光純薬株式会社)
A8:硫酸亜鉛(商品名:硫酸亜鉛、メーカー:富士フィルム和光純薬株式会社)
A9:フッ化スズ(商品名:フッ化スズ、メーカー:富士フィルム和光純薬株式会社)
A10:乳酸アルミニウム(商品名:乳酸アルミニウム、メーカー:富士フィルム和光純薬株式会社)
A11:硝酸カリウム(商品名:硝酸カリウム、メーカー:大塚化学株式会社)
A12:水酸化カリウム
A13:クエン酸カリウム
A14:塩化カリウム
A15:硫酸カリウム <Raw materials used>
-(A) component-
A1: Copper gluconate (trade name: copper gluconate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A2: Copper citrate (trade name: copper citrate, manufacturer: Kanto Chemical Co., Ltd.)
A3: Copper sulfate (trade name: copper sulfate, manufacturer: Kanto Chemical Co., Ltd.)
A4: Zinc chloride (trade name: zinc chloride, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A5: Zinc citrate (trade name: zinc citrate, manufacturer: Kanto Chemical Co., Ltd.)
A6: Zinc gluconate (trade name: zinc gluconate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A7: Zinc acetate (trade name: zinc acetate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A8: Zinc sulfate (trade name: zinc sulfate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A9: Tin fluoride (trade name: tin fluoride, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A10: Aluminum lactate (trade name: aluminum lactate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A11: Potassium nitrate (trade name: potassium nitrate, manufacturer: Otsuka Chemical Co., Ltd.)
A12: Potassium hydroxide A13: Potassium citrate A14: Potassium chloride A15: Potassium sulfate
―(A)成分―
A1:グルコン酸銅(商品名:グルコン酸銅、メーカー:富士フィルム和光純薬株式会社)
A2:クエン酸銅(商品名:クエン酸銅、メーカー:関東化学株式会社)
A3:硫酸銅(商品名:硫酸銅、メーカー:関東化学株式会社)
A4:塩化亜鉛(商品名:塩化亜鉛、メーカー:富士フィルム和光純薬株式会社)
A5:クエン酸亜鉛(商品名:クエン酸亜鉛、メーカー:関東化学株式会社)
A6:グルコン酸亜鉛(商品名:グルコン酸亜鉛、メーカー:富士フィルム和光純薬株式会社)
A7:酢酸亜鉛(商品名:酢酸亜鉛、メーカー:富士フィルム和光純薬株式会社)
A8:硫酸亜鉛(商品名:硫酸亜鉛、メーカー:富士フィルム和光純薬株式会社)
A9:フッ化スズ(商品名:フッ化スズ、メーカー:富士フィルム和光純薬株式会社)
A10:乳酸アルミニウム(商品名:乳酸アルミニウム、メーカー:富士フィルム和光純薬株式会社)
A11:硝酸カリウム(商品名:硝酸カリウム、メーカー:大塚化学株式会社)
A12:水酸化カリウム
A13:クエン酸カリウム
A14:塩化カリウム
A15:硫酸カリウム <Raw materials used>
-(A) component-
A1: Copper gluconate (trade name: copper gluconate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A2: Copper citrate (trade name: copper citrate, manufacturer: Kanto Chemical Co., Ltd.)
A3: Copper sulfate (trade name: copper sulfate, manufacturer: Kanto Chemical Co., Ltd.)
A4: Zinc chloride (trade name: zinc chloride, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A5: Zinc citrate (trade name: zinc citrate, manufacturer: Kanto Chemical Co., Ltd.)
A6: Zinc gluconate (trade name: zinc gluconate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A7: Zinc acetate (trade name: zinc acetate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A8: Zinc sulfate (trade name: zinc sulfate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A9: Tin fluoride (trade name: tin fluoride, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A10: Aluminum lactate (trade name: aluminum lactate, manufacturer: Fujifilm Wako Pure Chemical Industries, Ltd.)
A11: Potassium nitrate (trade name: potassium nitrate, manufacturer: Otsuka Chemical Co., Ltd.)
A12: Potassium hydroxide A13: Potassium citrate A14: Potassium chloride A15: Potassium sulfate
―(B)成分及びその代替成分―
B:N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド(商品名:CA370、メーカー:高砂香料工業株式会社)
N-エチル-p-メンタン-3-カルボキサミド(商品名:WS-3、メーカー:シムライズジャパン社)
3-L-メントキシプロパン-1,2-ジオール(メーカー:高砂香料工業株式会社)
(1R,2S,5R)-N-(4-(シアノメチル)フェニル)メンチルカルボキサミド(商品名:Evercool180、メーカー:Givaudan社) -Component (B) and its alternative component-
B: N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide (trade name: CA370, manufacturer: Takasago International Corporation)
N-ethyl-p-menthane-3-carboxamide (trade name: WS-3, manufacturer: Simrise Japan)
3-L-menthoxypropane-1,2-diol (manufacturer: Takasago International Corporation)
(1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthylcarboxamide (trade name: Evercool180, manufacturer: Givaudan)
B:N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド(商品名:CA370、メーカー:高砂香料工業株式会社)
N-エチル-p-メンタン-3-カルボキサミド(商品名:WS-3、メーカー:シムライズジャパン社)
3-L-メントキシプロパン-1,2-ジオール(メーカー:高砂香料工業株式会社)
(1R,2S,5R)-N-(4-(シアノメチル)フェニル)メンチルカルボキサミド(商品名:Evercool180、メーカー:Givaudan社) -Component (B) and its alternative component-
B: N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide (trade name: CA370, manufacturer: Takasago International Corporation)
N-ethyl-p-menthane-3-carboxamide (trade name: WS-3, manufacturer: Simrise Japan)
3-L-menthoxypropane-1,2-diol (manufacturer: Takasago International Corporation)
(1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthylcarboxamide (trade name: Evercool180, manufacturer: Givaudan)
―任意成分―
アネトール(商品名:アネトール、メーカー:ナカライテスク株式会社)
研磨性シリカ(商品名:Tixosil(登録商標)73、メーカー:Solvay社)
ソルビット液(70%)(メーカー:三菱商事ライフサイエンス株式会社)
プロピレングリコール(メーカー:ADEKA社)
増粘性シリカ(商品名:カープレックス(登録商標)#67、メーカー:DSLジャパン株式会社)
カルボキシメチルセルロースナトリウム(商品名:CMC1260、メーカー:ダイセルファインケム株式会社)
ラウリル硫酸ナトリウム(メーカー:BASF社)
フッ化ナトリウム(メーカー:ステラケミファ株式会社)
サッカリンナトリウム(メーカー:愛三化学工業株式会社)
上記以外の成分については医薬部外品原料規格2006に適合した原料を用いた。 -Optional Ingredients-
Anethole (Product name: Anethole, Manufacturer: Nacalai Tesque Co., Ltd.)
Abrasive silica (trade name: Tixosil (registered trademark) 73, manufacturer: Solvay)
Sorbit liquid (70%) (manufacturer: Mitsubishi Corporation Life Sciences Corporation)
Propylene glycol (manufacturer: ADEKA)
Thickening silica (trade name: Carplex (registered trademark) #67, manufacturer: DSL Japan Co., Ltd.)
Carboxymethyl cellulose sodium (trade name: CMC1260, manufacturer: Daicel Finechem Co., Ltd.)
Sodium lauryl sulfate (manufacturer: BASF)
Sodium fluoride (manufacturer: Stella Chemifa Co., Ltd.)
Saccharin sodium (manufacturer: Aisan Chemical Industry Co., Ltd.)
For ingredients other than the above, raw materials conforming to the Standards for Quasi-drug Ingredients 2006 were used.
アネトール(商品名:アネトール、メーカー:ナカライテスク株式会社)
研磨性シリカ(商品名:Tixosil(登録商標)73、メーカー:Solvay社)
ソルビット液(70%)(メーカー:三菱商事ライフサイエンス株式会社)
プロピレングリコール(メーカー:ADEKA社)
増粘性シリカ(商品名:カープレックス(登録商標)#67、メーカー:DSLジャパン株式会社)
カルボキシメチルセルロースナトリウム(商品名:CMC1260、メーカー:ダイセルファインケム株式会社)
ラウリル硫酸ナトリウム(メーカー:BASF社)
フッ化ナトリウム(メーカー:ステラケミファ株式会社)
サッカリンナトリウム(メーカー:愛三化学工業株式会社)
上記以外の成分については医薬部外品原料規格2006に適合した原料を用いた。 -Optional Ingredients-
Anethole (Product name: Anethole, Manufacturer: Nacalai Tesque Co., Ltd.)
Abrasive silica (trade name: Tixosil (registered trademark) 73, manufacturer: Solvay)
Sorbit liquid (70%) (manufacturer: Mitsubishi Corporation Life Sciences Corporation)
Propylene glycol (manufacturer: ADEKA)
Thickening silica (trade name: Carplex (registered trademark) #67, manufacturer: DSL Japan Co., Ltd.)
Carboxymethyl cellulose sodium (trade name: CMC1260, manufacturer: Daicel Finechem Co., Ltd.)
Sodium lauryl sulfate (manufacturer: BASF)
Sodium fluoride (manufacturer: Stella Chemifa Co., Ltd.)
Saccharin sodium (manufacturer: Aisan Chemical Industry Co., Ltd.)
For ingredients other than the above, raw materials conforming to the Standards for Quasi-drug Ingredients 2006 were used.
<評価方法>
被験者4名によって評価した。歯磨剤の場合、歯ブラシ(クリニカアドバンテージ歯ブラシ、4列コンパクトふつう、ライオン(株)製)にサンプルの歯磨剤組成物1gを載せ、3分間歯みがきを行った後、10mLの水で1回、口腔内をすすいだ。マウススプレーの場合、口腔内に適量を噴霧した。使用直後の口腔内の金属味と、使用後30分後に水を飲んだ際の金属味を、それぞれ下記の評点基準によって判定し、4名の平均点を求め、下記の評価基準で評価した。 <Evaluation method>
It was evaluated by 4 subjects. In the case of a dentifrice, 1 g of the sample dentifrice composition was placed on a toothbrush (clinica advantage toothbrush, 4-row compact normal, manufactured by Lion Co., Ltd.), and after brushing the teeth for 3 minutes, 10 mL of water was once applied to the oral cavity. rinsed out. In the case of mouth spray, an appropriate amount was sprayed into the oral cavity. The metallic taste in the oral cavity immediately after use and the metallic taste when drinking water 30 minutes after use were evaluated according to the following scoring criteria.
被験者4名によって評価した。歯磨剤の場合、歯ブラシ(クリニカアドバンテージ歯ブラシ、4列コンパクトふつう、ライオン(株)製)にサンプルの歯磨剤組成物1gを載せ、3分間歯みがきを行った後、10mLの水で1回、口腔内をすすいだ。マウススプレーの場合、口腔内に適量を噴霧した。使用直後の口腔内の金属味と、使用後30分後に水を飲んだ際の金属味を、それぞれ下記の評点基準によって判定し、4名の平均点を求め、下記の評価基準で評価した。 <Evaluation method>
It was evaluated by 4 subjects. In the case of a dentifrice, 1 g of the sample dentifrice composition was placed on a toothbrush (clinica advantage toothbrush, 4-row compact normal, manufactured by Lion Co., Ltd.), and after brushing the teeth for 3 minutes, 10 mL of water was once applied to the oral cavity. rinsed out. In the case of mouth spray, an appropriate amount was sprayed into the oral cavity. The metallic taste in the oral cavity immediately after use and the metallic taste when drinking water 30 minutes after use were evaluated according to the following scoring criteria.
<口腔内の金属味>
評点基準
5:全く感じない
4:ほとんど感じない
3:やや感じるが、許容範囲内で問題ないレベル
2:感じる
1:非常に感じる
評価基準
◎:4点以上
○:3点以上4点未満
×:3点未満 <Metallic taste in the oral cavity>
Scoring criteria 5: Not felt at all 4: Hardly felt 3: Slightly felt but acceptable level 2: Feeled 1: Very felt Evaluation criteria ◎: 4 points or more ○: 3 points or more and less than 4 points ×: less than 3 points
評点基準
5:全く感じない
4:ほとんど感じない
3:やや感じるが、許容範囲内で問題ないレベル
2:感じる
1:非常に感じる
評価基準
◎:4点以上
○:3点以上4点未満
×:3点未満 <Metallic taste in the oral cavity>
Scoring criteria 5: Not felt at all 4: Hardly felt 3: Slightly felt but acceptable level 2: Feeled 1: Very felt Evaluation criteria ◎: 4 points or more ○: 3 points or more and less than 4 points ×: less than 3 points
〔表の脚注〕
* 比較例4は、(1R,2S,5R)-N-(4-(シアノメチル)フェニル)メンチルカルボキサミド由来の刺激が強く、評価ができなかった。
** 香料の組成は以下の通りである。
ペパーミント油 50質量%
ペパーミント精製油(前流部20%カット) 5質量%
ペパーミント精製油(前流部・後流部15%カット) 5質量%
スペアミント油 1質量%
スペアミント精製油(前流部20%カット) 1質量%
和種ハッカ油 1質量%
和種ハッカ精製油(前流部30%カット) 1質量%
メントール 10質量%
カルボン 1質量%
溶剤 残部
合計 100質量% [Table footnote]
* In Comparative Example 4, the stimulus derived from (1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthylcarboxamide was strong and could not be evaluated.
** The composition of the perfume is as follows.
Peppermint oil 50% by mass
Peppermint refined oil (20% cut in the upstream part) 5% by mass
Peppermint refined oil (15% cut in the front and back streams) 5% by mass
Spearmint oil 1% by mass
Spearmint refined oil (20% cut in the upstream part) 1% by mass
Japanese peppermint oil 1% by mass
Japanese peppermint refined oil (30% cut in the upstream part) 1% by mass
Menthol 10% by mass
Carvone 1% by mass
solvent balance
Total 100% by mass
* 比較例4は、(1R,2S,5R)-N-(4-(シアノメチル)フェニル)メンチルカルボキサミド由来の刺激が強く、評価ができなかった。
** 香料の組成は以下の通りである。
ペパーミント油 50質量%
ペパーミント精製油(前流部20%カット) 5質量%
ペパーミント精製油(前流部・後流部15%カット) 5質量%
スペアミント油 1質量%
スペアミント精製油(前流部20%カット) 1質量%
和種ハッカ油 1質量%
和種ハッカ精製油(前流部30%カット) 1質量%
メントール 10質量%
カルボン 1質量%
溶剤 残部
合計 100質量% [Table footnote]
* In Comparative Example 4, the stimulus derived from (1R,2S,5R)-N-(4-(cyanomethyl)phenyl)menthylcarboxamide was strong and could not be evaluated.
** The composition of the perfume is as follows.
Peppermint oil 50% by mass
Peppermint refined oil (20% cut in the upstream part) 5% by mass
Peppermint refined oil (15% cut in the front and back streams) 5% by mass
Spearmint oil 1% by mass
Spearmint refined oil (20% cut in the upstream part) 1% by mass
Japanese peppermint oil 1% by mass
Japanese peppermint refined oil (30% cut in the upstream part) 1% by mass
Menthol 10% by mass
Carvone 1% by mass
solvent balance
Total 100% by mass
A成分と、B成分の代わりに他の各種冷感剤を含む比較例1~4では、使用直後の金属味を抑制できても使用30分後の金属味を抑制できなかったか、又は、両方を抑制できなかった(表6)。また、代替成分としてアネトールを含み、アネトールとソルビトールの比率が1:210である比較例5でも、使用30分後の金属味を抑制できなかった(表6)。これに対し、A及びB成分を含有する実施例1~22は、いずれも、使用直後及び使用30分後の金属味を抑制できていた(表1~5)。
これらの結果は、本発明によれば、金属イオンを放出する化合物を含む口腔用組成物において、上記化合物に起因する使用中及び使用後の金属味を抑制できることを示している。 In Comparative Examples 1 to 4 containing the A component and various other cooling agents instead of the B component, the metallic taste immediately after use could be suppressed, but the metallic taste could not be suppressed after 30 minutes of use, or both. could not be suppressed (Table 6). Moreover, even in Comparative Example 5, in which anethole was included as an alternative component and the ratio of anethole and sorbitol was 1:210, the metallic taste after 30 minutes of use could not be suppressed (Table 6). In contrast, all of Examples 1 to 22 containing the A and B components could suppress the metallic taste immediately after use and 30 minutes after use (Tables 1 to 5).
These results show that, according to the present invention, an oral composition containing a compound that releases metal ions can suppress metallic taste caused by the compound during and after use.
これらの結果は、本発明によれば、金属イオンを放出する化合物を含む口腔用組成物において、上記化合物に起因する使用中及び使用後の金属味を抑制できることを示している。 In Comparative Examples 1 to 4 containing the A component and various other cooling agents instead of the B component, the metallic taste immediately after use could be suppressed, but the metallic taste could not be suppressed after 30 minutes of use, or both. could not be suppressed (Table 6). Moreover, even in Comparative Example 5, in which anethole was included as an alternative component and the ratio of anethole and sorbitol was 1:210, the metallic taste after 30 minutes of use could not be suppressed (Table 6). In contrast, all of Examples 1 to 22 containing the A and B components could suppress the metallic taste immediately after use and 30 minutes after use (Tables 1 to 5).
These results show that, according to the present invention, an oral composition containing a compound that releases metal ions can suppress metallic taste caused by the compound during and after use.
以下、処方例を示す。処方例において、香料は、実施例1~22で用いたものと同様である。
A prescription example is shown below. In the formulation examples, the perfumes are the same as those used in Examples 1-22.
処方例1:洗口剤
(A1):グルコン酸銅 0.5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0005質量%
エタノール 2.0質量%
クエン酸 0.05質量%
クエン酸ナトリウム 0.3質量%
ポリオキシエチレン(60)硬化ヒマシ油 0.5質量%
塩化セチルピリジニウム 0.05質量%
パラオキシ安息香酸メチル 0.25質量%
香料 1質量%
水 残部
計 100質量%
(B)/(A)=0.001 Formulation Example 1: Mouthwash (A1): Copper gluconate 0.5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0005% by mass
Ethanol 2.0% by mass
Citric acid 0.05% by mass
Sodium citrate 0.3% by mass
Polyoxyethylene (60) hydrogenated castor oil 0.5% by mass
Cetylpyridinium chloride 0.05% by mass
Methyl paraoxybenzoate 0.25% by mass
Perfume 1% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.001
(A1):グルコン酸銅 0.5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0005質量%
エタノール 2.0質量%
クエン酸 0.05質量%
クエン酸ナトリウム 0.3質量%
ポリオキシエチレン(60)硬化ヒマシ油 0.5質量%
塩化セチルピリジニウム 0.05質量%
パラオキシ安息香酸メチル 0.25質量%
香料 1質量%
水 残部
計 100質量%
(B)/(A)=0.001 Formulation Example 1: Mouthwash (A1): Copper gluconate 0.5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0005% by mass
Ethanol 2.0% by mass
Citric acid 0.05% by mass
Sodium citrate 0.3% by mass
Polyoxyethylene (60) hydrogenated castor oil 0.5% by mass
Cetylpyridinium chloride 0.05% by mass
Methyl paraoxybenzoate 0.25% by mass
Perfume 1% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.001
処方例2:洗口剤
(A1):グルコン酸銅 0.5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0005質量%
プロピレングリコール 3.0質量%
クエン酸 0.05質量%
クエン酸ナトリウム 0.3質量%
ポリオキシエチレン(60)硬化ヒマシ油 0.5質量%
塩化セチルピリジニウム 0.05質量%
パラオキシ安息香酸メチル 0.25質量%
香料 1質量%
水 残部
計 100質量%
(B)/(A)=0.001 Formulation Example 2: Mouthwash (A1): Copper gluconate 0.5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0005% by mass
Propylene glycol 3.0% by mass
Citric acid 0.05% by mass
Sodium citrate 0.3% by mass
Polyoxyethylene (60) hydrogenated castor oil 0.5% by mass
Cetylpyridinium chloride 0.05% by mass
Methyl paraoxybenzoate 0.25% by mass
Perfume 1% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.001
(A1):グルコン酸銅 0.5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0005質量%
プロピレングリコール 3.0質量%
クエン酸 0.05質量%
クエン酸ナトリウム 0.3質量%
ポリオキシエチレン(60)硬化ヒマシ油 0.5質量%
塩化セチルピリジニウム 0.05質量%
パラオキシ安息香酸メチル 0.25質量%
香料 1質量%
水 残部
計 100質量%
(B)/(A)=0.001 Formulation Example 2: Mouthwash (A1): Copper gluconate 0.5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0005% by mass
Propylene glycol 3.0% by mass
Citric acid 0.05% by mass
Sodium citrate 0.3% by mass
Polyoxyethylene (60) hydrogenated castor oil 0.5% by mass
Cetylpyridinium chloride 0.05% by mass
Methyl paraoxybenzoate 0.25% by mass
Perfume 1% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.001
処方例3:歯磨剤
(A11):硝酸カリウム 5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.005質量%
プロピレングリコール 3.0質量%
ソルビット液(70%) 42.0質量%
無水ケイ酸 15.0質量%
ポリアクリル酸ナトリウム 0.7質量%
ポリエチレングリコール400 0.3質量%
キサンタンガム 1.6質量%
カラギーナン 0.2質量%
ヤシ油脂肪酸アミドプロピルベタイン液 1.0質量%
アルギン酸ナトリウム 0.3質量%
ラウロイルサルコシンナトリウム 0.2質量%
テトラデセンスルホン酸ナトリウム 0.4質量%
ラウロイルメチルタウリンナトリウム 0.5質量%
ポリオキシエチレン(60)硬化ヒマシ油 1.0質量%
ポリオキシエチレン(10)ステアリルエーテル 1.5質量%
モノラウリン酸ポリグリセリル 0.1質量%
トコフェロール酢酸エステル 0.2質量%
デキストラナーゼ(13,000単位/g) 0.19質量%
フッ化ナトリウム 0.21質量%
モノフルオロリン酸ナトリウム 0.36質量%
DL-アラニン 0.5質量%
DL-ピロリドンカルボン酸ナトリウム液 7.0質量%
ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド
0.02質量%
サッカリンナトリウム 0.08質量%
酸化チタン 0.6質量%
香料 1.2質量%
水 残部
計 100質量%
(B)/(A)=0.001 Formulation Example 3: Toothpaste (A11): Potassium nitrate 5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.005% by mass
Propylene glycol 3.0% by mass
Sorbit liquid (70%) 42.0% by mass
Silicic anhydride 15.0% by mass
Sodium polyacrylate 0.7% by mass
Polyethylene glycol 400 0.3% by mass
Xanthan gum 1.6% by mass
Carrageenan 0.2% by mass
Coconut fatty acid amidopropyl betaine liquid 1.0% by mass
Sodium alginate 0.3% by mass
Sodium lauroyl sarcosinate 0.2% by mass
Sodium tetradecene sulfonate 0.4% by mass
Sodium lauroyl methyl taurate 0.5% by mass
Polyoxyethylene (60) hydrogenated castor oil 1.0% by mass
Polyoxyethylene (10) stearyl ether 1.5% by mass
Polyglyceryl monolaurate 0.1% by mass
Tocopherol acetate 0.2% by mass
Dextranase (13,000 units/g) 0.19 wt%
Sodium fluoride 0.21% by mass
Sodium monofluorophosphate 0.36% by mass
DL-alanine 0.5% by mass
Sodium DL-pyrrolidonecarboxylate liquid 7.0% by mass
Hydroxyethyl cellulose dimethyl diallyl ammonium chloride 0.02% by mass
Saccharin sodium 0.08% by mass
Titanium oxide 0.6% by mass
Perfume 1.2% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.001
(A11):硝酸カリウム 5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.005質量%
プロピレングリコール 3.0質量%
ソルビット液(70%) 42.0質量%
無水ケイ酸 15.0質量%
ポリアクリル酸ナトリウム 0.7質量%
ポリエチレングリコール400 0.3質量%
キサンタンガム 1.6質量%
カラギーナン 0.2質量%
ヤシ油脂肪酸アミドプロピルベタイン液 1.0質量%
アルギン酸ナトリウム 0.3質量%
ラウロイルサルコシンナトリウム 0.2質量%
テトラデセンスルホン酸ナトリウム 0.4質量%
ラウロイルメチルタウリンナトリウム 0.5質量%
ポリオキシエチレン(60)硬化ヒマシ油 1.0質量%
ポリオキシエチレン(10)ステアリルエーテル 1.5質量%
モノラウリン酸ポリグリセリル 0.1質量%
トコフェロール酢酸エステル 0.2質量%
デキストラナーゼ(13,000単位/g) 0.19質量%
フッ化ナトリウム 0.21質量%
モノフルオロリン酸ナトリウム 0.36質量%
DL-アラニン 0.5質量%
DL-ピロリドンカルボン酸ナトリウム液 7.0質量%
ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド
0.02質量%
サッカリンナトリウム 0.08質量%
酸化チタン 0.6質量%
香料 1.2質量%
水 残部
計 100質量%
(B)/(A)=0.001 Formulation Example 3: Toothpaste (A11): Potassium nitrate 5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.005% by mass
Propylene glycol 3.0% by mass
Sorbit liquid (70%) 42.0% by mass
Silicic anhydride 15.0% by mass
Sodium polyacrylate 0.7% by mass
Polyethylene glycol 400 0.3% by mass
Xanthan gum 1.6% by mass
Carrageenan 0.2% by mass
Coconut fatty acid amidopropyl betaine liquid 1.0% by mass
Sodium alginate 0.3% by mass
Sodium lauroyl sarcosinate 0.2% by mass
Sodium tetradecene sulfonate 0.4% by mass
Sodium lauroyl methyl taurate 0.5% by mass
Polyoxyethylene (60) hydrogenated castor oil 1.0% by mass
Polyoxyethylene (10) stearyl ether 1.5% by mass
Polyglyceryl monolaurate 0.1% by mass
Tocopherol acetate 0.2% by mass
Dextranase (13,000 units/g) 0.19 wt%
Sodium fluoride 0.21% by mass
Sodium monofluorophosphate 0.36% by mass
DL-alanine 0.5% by mass
Sodium DL-pyrrolidonecarboxylate liquid 7.0% by mass
Hydroxyethyl cellulose dimethyl diallyl ammonium chloride 0.02% by mass
Saccharin sodium 0.08% by mass
Titanium oxide 0.6% by mass
Perfume 1.2% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.001
処方例4:歯磨剤
(A11):硝酸カリウム 5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0005質量%
プロピレングリコール 5.0質量%
ポリエチレングリコール400 1.0質量%
ソルビット液(70%) 45.0質量%
無水ケイ酸 13.0質量%
ポリアクリル酸ナトリウム 0.6質量%
キサンタンガム 1.1質量%
カルボキシメチルセルロースナトリウム 0.1質量%
アルギン酸ナトリウム 0.6質量%
ヤシ油脂肪酸アミドプロピルベタイン液 2.0質量%
ラウロイルサルコシンナトリウム 0.1質量%
ラウロイルメチルタウリンナトリウム 0.3質量%
テトラデセンスルホン酸ナトリウム 0.3質量%
ポリオキシエチレン(20)硬化ヒマシ油 2.0質量%
ポリオキシエチレン(5)ステアリルエーテル 1.5質量%
モノラウリン酸ポリグリセリル 0.1質量%
オウバクエキス 0.02質量%
トコフェロール酢酸エステル 0.1質量%
グリチルレチン酸 0.05質量%
デキストラナーゼ(13,000単位/g) 0.15質量%
トラネキサム酸 0.05質量%
フッ化ナトリウム 0.32質量%
DL-アラニン 0.15質量%
DL-ピロリドンカルボン酸ナトリウム液 6.0質量%
ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド
0.05質量%
サッカリンナトリウム 0.11質量%
キシリトール 0.09質量%
酸化チタン 0.4質量%
雲母チタン 0.2質量%
香料 1.3質量%
水 残部
計 100質量%
(B)/(A)=0.0001 Formulation Example 4: Toothpaste (A11): Potassium nitrate 5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0005% by mass
Propylene glycol 5.0% by mass
Polyethylene glycol 400 1.0% by mass
Sorbit liquid (70%) 45.0% by mass
Silicic anhydride 13.0% by mass
Sodium polyacrylate 0.6% by mass
Xanthan gum 1.1% by mass
Carboxymethylcellulose sodium 0.1% by mass
Sodium alginate 0.6% by mass
Coconut fatty acid amidopropyl betaine liquid 2.0% by mass
Sodium lauroyl sarcosinate 0.1% by mass
Sodium lauroyl methyl taurate 0.3% by mass
Sodium tetradecene sulfonate 0.3% by mass
Polyoxyethylene (20) hydrogenated castor oil 2.0% by mass
Polyoxyethylene (5) stearyl ether 1.5% by mass
Polyglyceryl monolaurate 0.1% by mass
Phellodendron bark extract 0.02% by mass
Tocopherol acetate 0.1% by mass
Glycyrrhetinic acid 0.05% by mass
Dextranase (13,000 units/g) 0.15 wt%
Tranexamic acid 0.05% by mass
Sodium fluoride 0.32% by mass
DL-alanine 0.15% by mass
Sodium DL-pyrrolidonecarboxylate liquid 6.0% by mass
Hydroxyethyl cellulose dimethyl diallyl ammonium chloride 0.05% by mass
Saccharin sodium 0.11% by mass
Xylitol 0.09% by mass
Titanium oxide 0.4% by mass
Mica titanium 0.2% by mass
Perfume 1.3% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.0001
(A11):硝酸カリウム 5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0005質量%
プロピレングリコール 5.0質量%
ポリエチレングリコール400 1.0質量%
ソルビット液(70%) 45.0質量%
無水ケイ酸 13.0質量%
ポリアクリル酸ナトリウム 0.6質量%
キサンタンガム 1.1質量%
カルボキシメチルセルロースナトリウム 0.1質量%
アルギン酸ナトリウム 0.6質量%
ヤシ油脂肪酸アミドプロピルベタイン液 2.0質量%
ラウロイルサルコシンナトリウム 0.1質量%
ラウロイルメチルタウリンナトリウム 0.3質量%
テトラデセンスルホン酸ナトリウム 0.3質量%
ポリオキシエチレン(20)硬化ヒマシ油 2.0質量%
ポリオキシエチレン(5)ステアリルエーテル 1.5質量%
モノラウリン酸ポリグリセリル 0.1質量%
オウバクエキス 0.02質量%
トコフェロール酢酸エステル 0.1質量%
グリチルレチン酸 0.05質量%
デキストラナーゼ(13,000単位/g) 0.15質量%
トラネキサム酸 0.05質量%
フッ化ナトリウム 0.32質量%
DL-アラニン 0.15質量%
DL-ピロリドンカルボン酸ナトリウム液 6.0質量%
ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド
0.05質量%
サッカリンナトリウム 0.11質量%
キシリトール 0.09質量%
酸化チタン 0.4質量%
雲母チタン 0.2質量%
香料 1.3質量%
水 残部
計 100質量%
(B)/(A)=0.0001 Formulation Example 4: Toothpaste (A11): Potassium nitrate 5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0005% by mass
Propylene glycol 5.0% by mass
Polyethylene glycol 400 1.0% by mass
Sorbit liquid (70%) 45.0% by mass
Silicic anhydride 13.0% by mass
Sodium polyacrylate 0.6% by mass
Xanthan gum 1.1% by mass
Carboxymethylcellulose sodium 0.1% by mass
Sodium alginate 0.6% by mass
Coconut fatty acid amidopropyl betaine liquid 2.0% by mass
Sodium lauroyl sarcosinate 0.1% by mass
Sodium lauroyl methyl taurate 0.3% by mass
Sodium tetradecene sulfonate 0.3% by mass
Polyoxyethylene (20) hydrogenated castor oil 2.0% by mass
Polyoxyethylene (5) stearyl ether 1.5% by mass
Polyglyceryl monolaurate 0.1% by mass
Phellodendron bark extract 0.02% by mass
Tocopherol acetate 0.1% by mass
Glycyrrhetinic acid 0.05% by mass
Dextranase (13,000 units/g) 0.15 wt%
Tranexamic acid 0.05% by mass
Sodium fluoride 0.32% by mass
DL-alanine 0.15% by mass
Sodium DL-pyrrolidonecarboxylate liquid 6.0% by mass
Hydroxyethyl cellulose dimethyl diallyl ammonium chloride 0.05% by mass
Saccharin sodium 0.11% by mass
Xylitol 0.09% by mass
Titanium oxide 0.4% by mass
Mica titanium 0.2% by mass
Perfume 1.3% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.0001
処方例5:歯磨剤
(A11):硝酸カリウム 5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0001質量%
プロピレングリコール 8.0質量%
ソルビット液(70%) 18.0質量%
グリセリン 15.5質量%
無水ケイ酸 18.0質量%
ポリアクリル酸ナトリウム 0.7質量%
キサンタンガム 0.8質量%
カルボキシメチルセルロースナトリウム 0.1質量%
アルギン酸ナトリウム 0.7質量%
ヤシ油脂肪酸アミドプロピルベタイン液 1.5質量%
ラウロイルサルコシンナトリウム 0.1質量%
テトラデセンスルホン酸ナトリウム 0.5質量%
ポリオキシエチレン(20)硬化ヒマシ油 3.0質量%
ポリオキシエチレン(5)ステアリルエーテル 0.5質量%
モノラウリン酸ポリグリセリル 0.5質量%
トコフェロール酢酸エステル 0.2質量%
イソプロピルメチルフェノール 0.05質量%
デキストラナーゼ(13,000単位/g) 0.13質量%
フッ化ナトリウム 0.32質量%
DL-アラニン 0.3質量%
DL-ピロリドンカルボン酸ナトリウム液 8.0質量%
ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド
0.1質量%
サッカリンナトリウム 0.06質量%
ステビアエキス 0.01質量%
酸化チタン 1.0質量%
香料 1.5質量%
水 残部
計 100質量%
(B)/(A)=0.00002 Formulation Example 5: Toothpaste (A11): Potassium nitrate 5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0001% by mass
Propylene glycol 8.0% by mass
Sorbit liquid (70%) 18.0% by mass
Glycerin 15.5% by mass
Silicic anhydride 18.0% by mass
Sodium polyacrylate 0.7% by mass
Xanthan gum 0.8% by mass
Carboxymethylcellulose sodium 0.1% by mass
Sodium alginate 0.7% by mass
Coconut fatty acid amidopropyl betaine liquid 1.5% by mass
Sodium lauroyl sarcosinate 0.1% by mass
Sodium tetradecene sulfonate 0.5% by mass
Polyoxyethylene (20) hydrogenated castor oil 3.0% by mass
Polyoxyethylene (5) stearyl ether 0.5% by mass
Polyglyceryl monolaurate 0.5% by mass
Tocopherol acetate 0.2% by mass
Isopropylmethylphenol 0.05% by mass
Dextranase (13,000 units/g) 0.13% by weight
Sodium fluoride 0.32% by mass
DL-alanine 0.3% by mass
Sodium DL-pyrrolidonecarboxylate liquid 8.0% by mass
Hydroxyethyl cellulose dimethyl diallyl ammonium chloride 0.1% by mass
Saccharin sodium 0.06% by mass
Stevia extract 0.01% by mass
Titanium oxide 1.0% by mass
Perfume 1.5% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.00002
(A11):硝酸カリウム 5質量%
(B):N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド 0.0001質量%
プロピレングリコール 8.0質量%
ソルビット液(70%) 18.0質量%
グリセリン 15.5質量%
無水ケイ酸 18.0質量%
ポリアクリル酸ナトリウム 0.7質量%
キサンタンガム 0.8質量%
カルボキシメチルセルロースナトリウム 0.1質量%
アルギン酸ナトリウム 0.7質量%
ヤシ油脂肪酸アミドプロピルベタイン液 1.5質量%
ラウロイルサルコシンナトリウム 0.1質量%
テトラデセンスルホン酸ナトリウム 0.5質量%
ポリオキシエチレン(20)硬化ヒマシ油 3.0質量%
ポリオキシエチレン(5)ステアリルエーテル 0.5質量%
モノラウリン酸ポリグリセリル 0.5質量%
トコフェロール酢酸エステル 0.2質量%
イソプロピルメチルフェノール 0.05質量%
デキストラナーゼ(13,000単位/g) 0.13質量%
フッ化ナトリウム 0.32質量%
DL-アラニン 0.3質量%
DL-ピロリドンカルボン酸ナトリウム液 8.0質量%
ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド
0.1質量%
サッカリンナトリウム 0.06質量%
ステビアエキス 0.01質量%
酸化チタン 1.0質量%
香料 1.5質量%
水 残部
計 100質量%
(B)/(A)=0.00002 Formulation Example 5: Toothpaste (A11): Potassium nitrate 5% by mass
(B): N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide 0.0001% by mass
Propylene glycol 8.0% by mass
Sorbit liquid (70%) 18.0% by mass
Glycerin 15.5% by mass
Silicic anhydride 18.0% by mass
Sodium polyacrylate 0.7% by mass
Xanthan gum 0.8% by mass
Carboxymethylcellulose sodium 0.1% by mass
Sodium alginate 0.7% by mass
Coconut fatty acid amidopropyl betaine liquid 1.5% by mass
Sodium lauroyl sarcosinate 0.1% by mass
Sodium tetradecene sulfonate 0.5% by mass
Polyoxyethylene (20) hydrogenated castor oil 3.0% by mass
Polyoxyethylene (5) stearyl ether 0.5% by mass
Polyglyceryl monolaurate 0.5% by mass
Tocopherol acetate 0.2% by mass
Isopropylmethylphenol 0.05% by mass
Dextranase (13,000 units/g) 0.13% by weight
Sodium fluoride 0.32% by mass
DL-alanine 0.3% by mass
Sodium DL-pyrrolidonecarboxylate liquid 8.0% by mass
Hydroxyethyl cellulose dimethyl diallyl ammonium chloride 0.1% by mass
Saccharin sodium 0.06% by mass
Stevia extract 0.01% by mass
Titanium oxide 1.0% by mass
Perfume 1.5% by mass
Water Remaining total 100% by mass
(B)/(A) = 0.00002
Claims (8)
- (A)下記(A-i)及び(A-ii)から選ばれる1種又は2種以上:
(A-i)銅、亜鉛、スズ、及びアルミニウムからなる群より選ばれる1種又は2種以上の金属イオンを放出する化合物、
(A-ii)カリウムイオンを放出する化合物
(B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミド
を含有する口腔用組成物。 (A) one or more selected from the following (Ai) and (A-ii):
(Ai) a compound that releases one or more metal ions selected from the group consisting of copper, zinc, tin, and aluminum;
(A-ii) a compound that releases potassium ions; and (B) N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide. - (B)/(A)が質量比として0.00001以上である請求項1に記載の口腔用組成物。 The composition for oral cavity according to claim 1, wherein (B)/(A) is 0.00001 or more as a mass ratio.
- (A-i)成分の量が5質量%以下である請求項1又は2に記載の口腔用組成物。 The oral cavity composition according to claim 1 or 2, wherein the amount of component (Ai) is 5% by mass or less.
- (A-ii)成分の量が10質量%以下である請求項1~3のいずれか1項に記載の口腔用組成物。 The oral cavity composition according to any one of claims 1 to 3, wherein the amount of component (A-ii) is 10% by mass or less.
- (B)成分の量が0.000005~0.1質量%である請求項1~4のいずれか1項に記載の口腔用組成物。 The oral composition according to any one of claims 1 to 4, wherein the amount of component (B) is 0.000005 to 0.1% by mass.
- (A-i)成分が、グルコン酸銅、クエン酸銅、硫酸銅、塩化亜鉛、クエン酸亜鉛、グルコン酸亜鉛、酢酸亜鉛、硫酸亜鉛、フッ化スズ、及び乳酸アルミニウムからなる群より選ばれる1種又は2種以上である、
請求項1~5のいずれか1項に記載の口腔用組成物。 (Ai) component is selected from the group consisting of copper gluconate, copper citrate, copper sulfate, zinc chloride, zinc citrate, zinc gluconate, zinc acetate, zinc sulfate, tin fluoride, and aluminum lactate 1 species or two or more species,
The oral composition according to any one of claims 1-5. - (A-ii)成分が、硝酸カリウム、水酸化カリウム、クエン酸カリウム、塩化カリウム、及び硫酸カリウムから選ばれる1種又は2種以上である、
請求項1~6のいずれか1項に記載の口腔用組成物。 (A-ii) component is one or more selected from potassium nitrate, potassium hydroxide, potassium citrate, potassium chloride, and potassium sulfate;
The oral composition according to any one of claims 1-6. - 歯磨剤、洗口剤、又はスプレー剤である請求項1~7のいずれか1項に記載の口腔用組成物。 The oral composition according to any one of claims 1 to 7, which is a dentifrice, mouthwash, or spray.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021-108069 | 2021-06-29 | ||
JP2021108069 | 2021-06-29 | ||
JP2022031181 | 2022-03-01 | ||
JP2022-031181 | 2022-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023277084A1 true WO2023277084A1 (en) | 2023-01-05 |
Family
ID=84691820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/026030 WO2023277084A1 (en) | 2021-06-29 | 2022-06-29 | Composition for oral cavity |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023277084A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003137755A (en) * | 2001-11-02 | 2003-05-14 | Lion Corp | Composition for oral cavity |
WO2018131575A1 (en) * | 2017-01-10 | 2018-07-19 | 高砂香料工業株式会社 | Methylmenthol derivative and cool-sensation imparter composition containing same |
JP2019116442A (en) * | 2017-12-27 | 2019-07-18 | ライオン株式会社 | Dentifrice composition |
JP2019182788A (en) * | 2018-04-11 | 2019-10-24 | ライオン株式会社 | Dentifrice composition |
-
2022
- 2022-06-29 WO PCT/JP2022/026030 patent/WO2023277084A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003137755A (en) * | 2001-11-02 | 2003-05-14 | Lion Corp | Composition for oral cavity |
WO2018131575A1 (en) * | 2017-01-10 | 2018-07-19 | 高砂香料工業株式会社 | Methylmenthol derivative and cool-sensation imparter composition containing same |
JP2019116442A (en) * | 2017-12-27 | 2019-07-18 | ライオン株式会社 | Dentifrice composition |
JP2019182788A (en) * | 2018-04-11 | 2019-10-24 | ライオン株式会社 | Dentifrice composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2997312C (en) | Oral care compositions comprising an amino acid, mixed zinc ion sources, and a cellulose/polysaccharide thickening system | |
JP5397204B2 (en) | Oral composition | |
JP7264049B2 (en) | oral composition | |
JP5420811B2 (en) | Oral composition | |
JP4846079B2 (en) | Oral composition | |
CN111902125B (en) | Oral composition and bitterness improver of alpha-olefin sulfonate | |
JP2019182788A (en) | Dentifrice composition | |
WO2023277084A1 (en) | Composition for oral cavity | |
JP2019112375A (en) | Oral composition | |
JP7347916B2 (en) | dentifrice composition | |
JP2011105682A (en) | Toothpaste composition | |
CN111031999B (en) | Toothpaste composition | |
JP6349709B2 (en) | Oral composition | |
JP2024000720A (en) | Composition for oral cavity | |
CN116634986A (en) | Oral composition | |
JP2022046221A (en) | Dentifrice composition | |
CN109953897B (en) | Oral composition and method for inhibiting discoloration thereof | |
WO2022102628A1 (en) | Composition for oral cavity | |
JP2022104290A (en) | Composition for oral cavity | |
CN116806140A (en) | Oral composition | |
WO2022138487A1 (en) | Oral composition | |
JP2024049467A (en) | Oral Composition | |
WO2022075422A1 (en) | Dentifrice composition | |
WO2022145160A1 (en) | Composition for oral cavity | |
WO2023063268A1 (en) | Non-aqueous composition for oral cavity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22833230 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |